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Abstract 
 Thyroid hormone receptor-alpha (TRα) functions in the nucleus as a transcription 
factor. Prior studies in non-neuronal cells have established that TRα shuttles rapidly 
between the nucleus and the cytoplasm; however, the physiological significance of 
shuttling remains unknown.  TRα plays an essential role in the growth, development and 
function of the nervous system, thus neuronal cells provide an important model system 
for studying TRα shuttling.  To better understand the properties of TRα shuttling in 
neuronal and non-neuronal cell lines, we compared the intracellular localization of full-
length TRα, individual TRα domains, and domain combinations. The four functional 
domains of TRα are the transactivation (A/B) domain which contains a novel nuclear 
localization sequence (NLS), the DNA-binding domain (DBD), the hinge domain (HD) 
which contains a classical bipartite NLS, and the ligand-binding domain (LBD). 
Expression vectors for green fluorescent protein (GFP) tagged individual and 
combination domains and GFP-tagged full-length TRα were transiently transfected into 
non-neuronal and neuronal cell lines. Fusion protein distribution patterns were visualized 
by fluorescence microscopy and scored for a nuclear, cytoplasmic or whole cell 
distribution. We found that the A/B and HD have NLS activity in both non-neuronal and 
neuronal cell lines but that the HD is likely to contain a stronger signal for import.  The 
most distinct cell-type specific difference in localization was a shift to the cytoplasm with 
these domains in neuronal cells.  In all cell lines, the DBD was found to shift the A/B 
domain to the nucleus but shift the HD to the cytoplasm.  The LBD of TRα showed 
strong export activity, as it completely reversed the nuclear localization of the HD alone 
in all cell lines.  Our findings suggest that there are differences in TRα localization 
between non-neuronal and neuronal cell lines, possibly providing an example of 
transcription factor regulation by compartmentalization. 
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Introduction 
Thyroid hormone receptor α (TRα) is a member of the nuclear receptor 
superfamily, a diverse set of proteins that regulates the transcription of genes involved in 
a vast number of physiological processes (Germain et al., 2006).  Nuclear receptors 
(NRs) modulate gene expression in response to their cognate ligand, typically small 
lipophilic molecules that pass rapidly through cellular membranes.  In this way, most 
ligands are quickly able to access their receptor and trigger changes in gene expression.  
Therefore, hormones and receptors comprise highly abbreviated signal transduction 
pathways.   Accordingly, disruption in NR signaling is implicated in a large number of 
human diseases, including cancer, infertility, obesity and diabetes.  An essential 
regulatory step in the activity of NRs, including TRα, is the translocation of the receptor 
from the site of synthesis in the cytoplasm to the genetic material in the nucleus.  In 
particular, errant regulation at this step leads to cancer. For instance, the oncogenic 
properties of v-erbA, a mutated form of TRα, are due to a mislocalization to the 
cytoplasm (Bonamy et al., 2005).  The mislocalization of other nuclear receptors, such 
as retinoid-X receptor and androgen receptor, has also been implicated in oncogenesis 
(Bonamy and Allison, 2006).  Thus, compartmentalization of transcription factors 
denotes a critical regulatory mechanism in eukaryotic cells.   
The division of eukaryotic cells into nuclear and cytoplasmic compartments 
provides a higher order of regulation of gene expression.  The nuclear compartment 
encloses DNA and transcription machinery, while the cytoplasm contains translation and 
energy production processes.  Thousands of molecules continuously exchange between 
these compartments, including mRNA, polymerases and transcription factors (Cook et 
al., 2007).  Previously thought to reside constitutively in the nucleus bound to DNA (Nagl 
et al., 1995), TRα is now known to shuttle rapidly between the nucleus and the 
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cytoplasm (Bunn et al., 2001; Grespin et al., 2008).  Nuclear import and export are 
mediated by specific directional signals in the functional domains of TRα; however, the 
specific contributions of the these domains to the steady-state distribution of the full-
length receptor remain unclear.  Therefore, the first overarching goal of this thesis 
research was to understand the shuttling properties of the functional domains of TRα.  
The shuttling dynamics of TRα to date have primarily been studied in non-
neuronal cell lines; however, TRα exerts critical regulatory action on many aspects of 
neuronal growth, development and function (Williams, 2008).  Prior studies in our lab 
have reported a more cytoplasmic distribution of TR in some neuronal tissues; therefore, 
an important question arises of whether cell-type specific differences exist in the 
shuttling of TRα within neuronal and non-neuronal cells.  Accordingly, the second overall 
objective of this thesis research was to compare the shuttling properties of the functional 
domains of TRα in neuronal and non-neuronal cell lines.    
The following sections provide background information about thyroid hormone 
signaling and transcriptional regulation of TR.  Next, the tissue-specific expression of TR 
isoforms is discussed in addition to TRα's specific roles in the nervous system.  Then, 
the modular structure of nuclear receptors is considered, along with the dynamics and 
regulation of nucleocytoplasmic transport.   
Thyroid Hormone 
Thyroid hormone (TH) is essential in all vertebrates in regulating metabolism, 
energy utilization and central nervous system development and function (Zhang and 
Lazar, 2000; Yen et al., 2006).  The two forms of TH, tyrosine-derived thyroxine (3,5,3',5'-
tetraiodothyronine, or T4) and triiodothyronine (3,3',5-triiodo-L-thyronine, or T3), are 
synthesized by the thyroid gland in the presence of iodine.  T4 is a prohormone and is 
converted at target tissues to the more biologically active T3 through the activity of 
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cellular deiodinases, which remove the 5’ iodine (Williams, 2008).  TH action is mediated 
at the genomic level by thyroid hormone receptors (TRs).  TRs belong to the family of 
class II nuclear receptors, which also includes the vitamin D receptor, retinoic acid 
receptor, retinoid-X receptor, and peroxisomal proliferator-activated receptor (Bain et al., 
2007).  Two genes, THRA and THRB, encode the major receptor isoforms TRα1, TRβ1 
and β2 (Flamant et al., 2006).  
Transcriptional Regulation by TRα 
TRα regulates the transcription of a specific subset of all the cells’ expressed 
genes (Ribeiro et al., 1995). The particular genes that TRα regulates have a consensus 
thyroid hormone response element (TRE) of AGGTCA.  The TRE can be in the form of a 
direct repeat, palindrome, inverted palindrome or isolated half-site (Bain et al., 2007).  
TRs bind TREs as monomers and/or homodimers, but predominantly bind at the 
response element as RXR/TR heterodimers (Zhang and Lazar, 2000).  TRα regulates 
transcription by recruiting coactivators and corepressors to the promoter regions of 
target genes.  An important aspect of TRα transcriptional regulation is that it can 
modulate gene expression in the presence and absence of TH.  In the classic model, 
TRα represses genes in cells where TH is not available and activates genes in those 
where TH is present.  Hence, in the absence of TH, the TRα transcriptional complex 
incorporates corepressor proteins that prevent gene expression.  In the presence of TH, 
the TRα complex releases those corepressors and recruits coactivating proteins, which 
enable the TRα regulatory group to carry out chromatin remodeling and transcriptional 
activation (Zhang and Lazar, 2000; Bain et al., 2007).  Alternatively, some genes are 
negatively regulated by TH, that is, they are repressed in the presence of hormone and 
activated in the absence of hormone (Yen, 2001).   
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Tissue Specific Expression of TRα 
While TRα expression is essentially ubiquitous throughout the body (Flamant et 
al., 2006), it is not present at the same level in every tissue.  An analysis of the mRNA 
from 33 human tissues reported that TRα is most highly transcribed in skeletal muscle, 
cerebellum, brain and heart tissue (Nishimura et al., 2004).  Between TRα and TRβ, 
TRα is estimated to account for 70-80% of total TR expression in the brain (Schwartz et 
al., 1992), suggesting that TRα is the major receptor for TH in the central nervous 
system.   
The Role of TRα in the Nervous System 
Multiple factors of TH and TR regulation are critical to correct nervous system 
development and function (Nunez et al., 2008; Williams, 2008).  A damaged or 
malfunctioning thyroid gland leads to decreased release of TH, called hypothyroidism 
(König and Neto, 2002).  This syndrome in adults leads to neurologic and psychiatric 
abnormalities including deficits in memory and the control of movement, which can 
usually be corrected with TH-replacement therapy.  Hypothyroidism in infants is 
associated with mild mental retardation; however, this can be prevented if TH-
replacement is targeted to a period shortly after birth, indicating that TH has 
developmental-stage specific functions that are essential to the correct maturation of the 
nervous system.  More severe deficits are seen with insufficient maternal iodine intake 
during pregnancy, which leads to an irreversible syndrome called cretinism.  Cretinism 
can involve acute mental retardation, deafness, and even paralysis of the lower limbs 
(König and Neto, 2002).  Therefore, it is clear that the thyroid system is essential to 
nervous system development and function.  More specifically, TRα has been shown to 
regulate the transcription of genes involved in neural development, mediate 
neurogenesis in the developing and adult brain, and control glial cell differentiation, 
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among other functions (König and Neto, 2002; Williams, 2008).   
TH and TRs are involved in the regulation of numerous genes involved in neural 
development.  Recently, a high throughput analysis of the genes that are up/down-
regulated upon TH treatment in the adult rat brain was performed (Diez et al., 2008).  To 
investigate TH-regulated genes, the researchers employed a DNA microarray and 
confirmed their results with a second microarray technique and real-time PCR.  The 
study found that a single large dose of TH caused an up-regulation of 149 genes and a 
down-regulation of 88 genes whereas multiple small doses of TH over a span of days 
caused an up-regulation of 18 genes and a down-regulation of one gene.  The genes 
affected by TH treatment are involved in a great variety of processes, including: G-
protein coupled signaling, brain enzymatic activity, neuroprotection, neurotransmitter 
transport and release, circadian rhythm regulation, and neurological pathogenesis, 
among others (Diez et al., 2008).  While the genes discovered in Diez et al. were due to 
the actions of both TR isoforms, other reports have found that TRα in particular directly 
regulates the expression of certain genes involved in neural development.  These 
include the genes encoding the transcription factors NGFI-A, c-MYC, and BTEB, which 
are involved in neurite outgrowth, and BDNF (brain-derived neurotrophic factor), which is 
involved in the growth and differentiation of new neurons and synapses (König and Neto, 
2002).  TRα also regulates the expression of a synaptogamin-related protein involved in 
neurotransmitter release and MBP, the basic building block of myelin (König and Neto, 
2002).  Through this regulation of specific genes, TR activity can lead to the commitment 
of a cell to a particular phenotype, in differentiation.   
TRα has been shown to mediate the generation of new neurons in the brain of 
the developing embryo and adult in a number of different organisms (Denver et al., 
2009; Lemkine et al., 2005); whereas TRβ was not found to be essential in these 
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processes.  For example, in the maturation of Xenopus laevis tadpoles to adult frogs 
TRα, and not TRβ, regulates brain cell proliferation (Denver et al., 2009).  Therefore, 
TRα mediates this specific progression of development in frogs.  Similarly, in the neural 
stem cell and progenitor cell populations of the subventricular zone in adult mice, there 
is specific expression of TRα and not TRβ (Lemkine et al., 2005). Researchers found 
that lowered TH levels in the subventricular zone led to a reduction in neural stem cell 
differentiation and an accumulation of non-mitotic progenitor cells.  The absence of TRα 
produced effects similar to those seen with lowered TH levels.  A return to normal TH 
levels restored the number of differentiating cells in the subventricular zone to pre-TH-
depletion numbers.  Therefore, this demonstrates that TRα is critical in successful adult 
neurogenesis in the subventricular zone (Lemkine et al., 2005).  These results are 
consistent with research in chick embryo neuroblasts (Lezoualc’h et al., 1995) and 
confirm that TH and TRα are essential activating factors in neural stem cell maturation.  
TRα is also essential to the normal timing of oligodendrocyte precursor cell 
differentiation (Billon et al., 2002).  Oligodendrocytes are glial cells that myelinate axons 
in the central nervous system. To investigate the role of TRα in oligodendrocyte 
precursor cell differentiation, studies have employed TRα-knockout mice and retrovirus-
mediated gene transfer.  In TRα knockout mice, oligodendrocyte development was 
delayed and precursor cells in these mice failed to differentiate in response to TH 
treatment.  On the other hand, over-expression of a TRα transgene in oligodendrocyte 
precursor cells led to accelerated TH-dependent differentiation.  Other studies have 
confirmed a 50-57% decrease of oligodendrocytes in the optic nerves of TRα-deficient 
mice and hypothyroid mice (Billon et al., 2002).  Intuitively, lower numbers of 
oligodendrocytes would lead to decreased myelination.  In support of this link, 
myelination is delayed in hypothyroid animals and accelerated in hyperthyroid animals.  
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Furthermore, TH has been shown to improve remyelination after an induced 
demyelination (Franco et al., 2008).  These results indicate that TH and TRα play an 
important role in oligodendrocyte development and myelination. 
A review of the role of TRα in the central nervous system reveals that it is 
essential to a variety of processes including the differentiation of neural stem cells and 
oligodendrocytes.  Notably, differentiation requires global changes in regulation that lead 
to a committed cellular phenotype.  Alterations in the regulation of nuclear transport may 
be one way in which neuronal cells achieve these changes.   
An Overview of Nucleocytoplasmic Transport 
 The nuclear envelope provides a functional separation between the genomic 
activity of the nucleus and the metabolic processes of the cytoplasm.  Consequently, a 
vast macromolecular exchange must occur continuously between the two compartments 
(Cook et al., 2007).  RNA transcripts synthesized in the nucleus are exported to be 
translated into proteins at ribosomal complexes located in the cytoplasm.  As these 
molecules exit the nucleus, histones, polymerases, transcription factors and many other 
nuclear-functioning proteins enter to perform their roles.  Certain proteins, including 
transcription factors, rapidly shuttle between the two compartments.  Bidirectional traffic 
across the nuclear envelope is highly regulated, as it involves specific pores through 
which transport must occur, adaptor/carrier proteins that facilitate the movement of cargo 
proteins, specific amino acid targeting sequences, and both energy-dependent and 
energy-independent processes (Figure 1).   
Transport across the nuclear membrane occurs through selective channels 
known as nuclear pore complexes (NPCs).  NPCs are massive protein complexes of 
about 40-60 MDa, composed of multiple copies of around 30 proteins called  
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Figure 1: Simplified Schematic of Nucleocytoplasmic Shuttling 
The upper portion of the figure depicts nuclear import.  NLS-containing cargo proteins 
(NLS, orange) bind to import factors (IMP) and translocate through the nuclear pore 
complex (NPC).  Once in the nucleus, RanGTP binds the import factor, triggering the 
release of the cargo (upper right).  The lower portion of the figure depicts nuclear export.  
Export factors (EXP) bind NES-containing cargo proteins (NES, blue) and RanGTP, then 
translocate through the NPC.  Once in the cytoplasm, RanGTP-hydrolysis to RanGDP 
causes cargo dissociation from the export factor (lower left).   
 
  
NPC 
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nucleoporins, or Nups.  The quaternary structure of the NPC delineates three 
characteristic elements: the nuclear basket, central core, and cytoplasmic fibrils (Tran 
and Wente, 2006).  The nuclear basket and cytoplasmic fibrils are the surfaces at which 
carrier proteins are recognized by the NPC. The central core is the channel through 
which cargo is transported.  Phenylalanine-glycine repeat domains of nucleoporins line 
the central transport channel and contribute to the NPC permeability barrier that 
precludes passage of molecules larger than 40 kDa (Terry, 2007).  For massive proteins 
to cross the nuclear membrane they must associate with nuclear transport chaperones, 
which are thought to have the biochemical properties necessary to dissolve the 
permeability barrier and thus, allow passage through the NPC (Frey and Görlich, 2007).  
The majority of nuclear transport chaperone proteins belong to the karyopherin-β family. 
These proteins include importins, exportins and a third category of factors that take part 
in both import and export (Cook et al., 2007; Sorokin et al., 2007).   
To associate with importins and enter the nucleus, prohibitively large proteins 
require a nuclear localization signal (NLS).  The most common types of NLS are 
monopartite or bipartite.  Monopartite NLS are a single cluster of three to five basic 
amino acid residues exemplified by the SV40 large T antigen NLS (PKKKRKV) and 
characterized loosely by the consensus sequence K(K/R)X(K/R) (Lange et al., 2007).  
The bipartite NLS is essentially two monopartite sequences separated by a 10-12 amino 
acid spacer.  In the classical model of nuclear import, a class of karyopherins known as 
“importin α” interacts with the NLS on the cargo protein.  The importin α/cargo complex 
then binds to importin β, a member of a second class of karyopherins known as “importin 
β’s.”  These proteins form a trimeric complex able to pass through the central channel of 
the NPC.  Alternatively, importin β itself and other members of the importin β family are 
able to bind NLS-containing cargoes directly, and carry them through the NPC (For 
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review see Görlich and Kotay, 1999; Cook et al., 2007; Stewart, 2007).  Once in the 
nucleus, the cargo is dissociated from the import factor through the binding of RanGTP, 
a process that confers energy-dependence to nuclear transport. 
 Export from the nucleus involves binding of specific export receptors (exportins) 
to nuclear export sequences (NES) in cargo proteins.  Unlike NLS, NES are much more 
difficult to identify.  The most well characterized class of export signals are the leucine-
rich NES associated with CRM-1 mediated nuclear export.  CRM-1 (chromosome region 
maintenance 1, or exportin 1) is a member of the karyopherin superfamily of transport 
receptors, and CRM-1-associated export constitutes the major pathway for export from 
the nucleus (Hutten and Kehlenbach, 2007). In contrast to import, RanGTP is required to 
assemble the export complex.  After assembly, the exportin-cargo-RanGTP trimer 
translocates through the NPC.  GTP hydrolysis in the cytoplasm triggers the release of 
cargo in the cytoplasm, and RanGDP and exportin recycle back to the nucleus.  
Leptomycin B (LMB) is a potent inhibitor of CRM1-dependent nuclear export and has 
been used extensively to study this pathway (Wolff et al., 1997; Yashiroda and Yoshida, 
2003).   
 Nuclear transport is an active process and depends on the energy gradient 
supplied by the Ran proteins.  Ran belongs to the Ras superfamily of small GTPases 
and cycles between a GTP- and GDP-bound state (Cook et al., 2007).  As mentioned 
above, the binding of RanGTP to importin inside the nucleus triggers cargo dissociation.  
Conversely, assembly of the export complex includes RanGTP.  Once in the cytoplasm, 
RanGTP hydrolysis to RanGDP causes cargo dissociation from exportin proteins.  
RanGEF (guanine nucleotide exchange factor) facilitates the exchange of GDP for GTP-
bound to Ran and is present in the nucleus whereas RanGAP (GTPase activating 
protein) facilitates GTP hydrolysis to GDP and is present in the cytoplasm (Sorokin et al., 
2007).  The sequestration of these key regulatory factors between the nucleus and the 
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cytoplasm creates the “Ran gradient,” with higher levels of RanGTP in the nucleus and 
higher levels of RanGDP in the cytoplasm (Stewart, 2007).  The Ran gradient confers 
directionality to nuclear import and represents an additional level of regulatory control.   
 In summary, import factors bind NLS-containing cargo proteins in the cytoplasm, 
pass through the NPC, and release the cargo in the nucleus upon binding with RanGTP.  
In contrast, export factors bind NES-containing cargo proteins in concurrence with 
RanGTP, pass through the NPC, and release the cargo in the cytoplasm upon RanGTP 
hydrolysis.   
The Modular Structure of TRα 
 NRs have a modular structure with four domains conserved across most classes: 
from N-terminal to C-terminal, the transactivation (A/B) domain, the DNA-binding 
domain, the hinge domain, and the ligand-binding domain.  The A/B domain is also 
known as the transcriptional activation function or AF-1 domain and is weakly conserved 
between nuclear receptors (Bain et al., 2007).  A/B is the principal region of nuclear 
receptors that interacts with corepressor and coactivator proteins in order to modulate 
transcriptional control.  In TRα, the A/B domain is comprised of amino acids 1-50.  A 
novel monopartite NLS has been identified in our lab in this region (M.S. Mavinakere and 
L.A. Allison, unpublished results).   
 The DNA binding domain (DBD) is the most conserved region of NRs.  It contains 
two cysteine-rich zinc-finger binding motifs, a distinctive feature of nuclear receptors 
(Mangelsdof, 1995).  This is the domain of TRα that mediates interaction between TRα 
and TREs in target genes.  Although the primary functions of the DBD are to determine 
the specificity and strength of response element binding, the DBD also participates in 
TR-RXR heterodimerization assembly (Bain et al., 2007) and acts as a target for post-
translational modification (Germain et al., 2006).  Interestingly, the DBD of the 
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glucocorticoid receptor (GR) is the primary binding site for calreticulin, a Ca2+-binding 
protein also involved in nuclear export (Sun et al., 2007; Kumar et al., 2006).  TRα 
nuclear export is mediated in part by calreticulin (Grespin et al., 2008); however, it has 
not been shown yet whether calreticulin binds with the DBD of TRα.   
 The hinge domain (HD), from amino acids 129-222 in TRα, is a sequence 
between the DBD and LBD that creates a turn in the three-dimensional structure of the 
protein.  All TR isoforms have this hinge region, suggesting that it is important for 
receptor function (Lee and Mahvadi, 1993; Bunn et al., 2001).  Research shows that the 
hinge region of TRα targets the protein to the nucleus and aids in DNA-binding and 
hormone-binding activities (Lee and Mahvadi, 1993).  Neutral amino acid substitutions in 
the hinge region were shown to reduce nuclear accumulation of TRα, confirming that it 
contains a bipartite NLS (Lee and Mahvadi, 1993).   
 The ligand binding domain (LBD) constitutes the C-terminal end of NRs, and is 
comprised of amino acids 223-490 in TRα.  It is moderately conserved among nuclear 
receptors, with sequence and structural differences related to the binding of specific 
ligands and coregulators.  Four structurally and functionally distinct motifs define LBD 
activity.  First, a dimerization surface mediates homo/hetero-dimerization; second, an 
interior ligand-binding pocket confers specificity and recognition of cognate ligand; third, 
a coregulator binding surface recruits protein complexes that up/down-regulate 
transcriptional activity; and fourth, an activation function helix (AF-2) mediates ligand-
dependent transactivation (Germain et al., 2006; Bain et al., 2007).  In addition to 
serving these functions, our lab has found that the LBD of TRα contains more than one 
NES (M.S. Mavinakere and L.A. Allison, unpublished results).   
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Characterizing the Nucleocytoplasmic Shuttling Properties of TRα 
TRα has been shown to rapidly shuttle in and out of the nucleus in studies on 
Xenopus oocytes and interspecies heterokaryon assays using non-neuronal cell lines 
(Bunn et al., 2001).  Given the critical role of TRα in the growth, development and 
function of the nervous system, it is of great interest to investigate the nuclear transport 
dynamics of TRα within neuronal cells.  Based on the presence of multiple signals for 
import/export, the nucleocytoplasmic shuttling of TRα appears to be regulated by a fine 
balance between nuclear import, nuclear retention and nuclear export.  To investigate 
this balance in this thesis research, TRα was separated into its individual functional 
domains and their localizations were observed in non-neuronal and neuronal cells.   
Specific Aims of Research 
 The overall aims of this thesis research were to investigate the shuttling 
properties of the individual functional domains of TRα and to compare and contrast their 
intracellular localization in non-neuronal and neuronal cells.  With this in mind, a number 
of specific questions were addressed: 
1. Do the A/B and hinge domains of TRα show NLS activity in all cell lines tested? 
2. How does the DNA-binding domain affect the NLS activity of the A/B and hinge 
domains? 
3. How does the ligand-binding domain affect the NLS activity of the hinge domain, 
both in the presence and absence of the DNA-binding domain? 
4. What are the differences in the nuclear transport activity of TRα functional 
domains between the non-neuronal and neuronal cell lines tested? 
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Materials and Methods 
Plasmids 
The individual and combination domain plasmid constructs were prepared by Dr. 
M. Mavinakere in the Allison lab.  In brief, primers were designed to amplify individual 
and combination DNA sequences by PCR.  The individual functional domains of TRα are 
the A/B domain, DNA-binding domain (DBD), hinge domain (HD) and ligand-binding 
domain (LBD).  The combination domains were A/B-DBD, DBD-HD, DBD-HD-LBD, and 
HD-LBD. RS-TRα (described in Bunn et al., 2001) was used as the template for PCR.  
PCR products were subsequently cloned into the pGFP-GST-GFP vector (constructed 
by Dr. G. Bonamy in the Allison lab).  The individual domains and the A/B-DBD 
combination were cloned using the Kpn I and Xba I restriction endonuclease sites 
whereas the remaining combinations were cloned using Hind III and Kpn I.  The GST 
and additional GFP coding region were included in this expression vector to increase the 
molecular mass of the fusion protein such that it would not passively diffuse through the 
nuclear pore complex.  An empty pGFP-GST-GFP vector was included in each 
experiment as a control.  The expression vector for full-length TRα, pGFP-TRα, contains 
rTRα-1 (rat) cDNA subcloned into the enhanced GFP expression plasmid pEGFP-C1 
(CLONTECH Laboratories, Inc. Palo Alto, CA) (Bunn et al., 2001). 
All plasmids were amplified in E.coli-DH5α and purified using a Qiagen Plasmid 
Midi Kit (Qiagen Inc., Valencia CA).  DNA purity and concentration were measured using 
a NanoDrop® ND-1000 full-spectrum UV/Vis spectrophotometer. 
Cell Culture 
Cells were cultured in 75 cm2 flasks (Nunc, T-75) in 20 ml growth medium at 37° 
C in 5% CO2 and 98% humidity in a CO2 incubator (Napco Series 8000 WJ, 
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ThermoScientific).  In general, for all cell lines the medium was changed every 48 hours 
Monday-Friday and the cells were subcultured over the weekend.   
 
Non-Neuronal 
AML-12 (mouse hepatocyte, ATCC, CRL-2254) cells were grown in DMEM/F-12 
with 10% Fetal Bovine Serum (FBS), supplemented with 200 μl ITS (Insulin-Transferrin-
Selenium, Invitrogen) and 20 μl Dexamethasone (1000X).  HeLa cells (human cervix 
adenocarcinoma, ATCC, CCL-2) were grown in MEM with 10% FBS.   
Neuronal 
PC-12 (rat adrenal medulla pheochromocytoma, ATCC, CRL-1721) cells were 
provided by Dr. R. Kuruvilla (Johns Hopkins University).  They were cultured in DMEM 
with 10% FBS.  SH-SY5Y (human neuroblastoma, ATCC, CRL-2266) cells were grown 
in MEM/F-12 with 10% FBS.  Both SH-SY5Y and PC-12 cells were supplemented with 
2% B-27 (50X, Invitrogen; Brewer et al., 1993) during routine passage and transfection.  
It should be noted that the neuronal cell lines were very difficult to maintain and 
transfect.  They grew very slowly and transfection efficiency was often very low; 
therefore, experiments had to be performed repeatedly to achieve even one successful 
transfection.  The protocol for transfection was optimized for these cell lines over many 
replicates (Table 1).  It was found that the neuronal cells needed to be seeded at a very 
high cell number relative to other cell lines in order to achieve enough fusion protein-
expressing cells to score. 
Transient Transfection 
Cells were prepared for transfection when they were >80% confluent.  First, the 
media was removed and the cells were rinsed with 10 ml Dulbecco's modified 
Phosphate Buffered Saline (D-PBS: 0.10 g KCl, 0.10 g KH2PO4, 4.00 g NaCl, and 1.08 g 
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Na2HPO4·7H2O in 500 ml ddH2O).  The D-PBS was aspirated and 2 ml 0.25% trypsin 
(protease) was added to break down the extracellular matrix and detach the cells from 
the bottom of the flask.  For HeLa and AML-12 cells, the trypsin was withdrawn after 2 
minutes.  For PC-12 and SH-SY5Y cells, withdrawal of the trypsin was not performed 
after the initial 2 minutes.  For each cell line, after 2 minutes of trypsin exposure the flask 
was placed in the 37°C incubator for an additional 2-4 minutes.  During this time cells 
were periodically monitored with a phase contrast microscope.  Once the cells had fully 
detached from the bottom of the flask, the flask was removed from the incubator.  HeLa 
and AML-12 cells were diluted in 8 ml of media and PC-12 and SH-SY5Y cells were 
diluted in 6 ml of media (because flasks still contained the 2 ml trypsin).  A 
hemacytometer was used to determine the cell number.  Cells were seeded at optimized 
numbers (Table 1) onto sterile 22 mm coverslips in 6-well plates (Corning).  Twenty-four 
hours after seeding, cells were transfected with 2 μg plasmid DNA and 4-8 μl 
LipofectAmine 2000 (Table 1) in Opti-MEM I Reduced Serum Medium (Invitrogen).   
Table 1 – Optimized Transfection Protocols for Each Cell Line 
 HeLa AML-12 PC-12 SH-SY5Y 
Cell Number 
(cells/well) 1.5-2 x 10
5 4-5 x 105 10-12 x 105 10-12 x 105 
Lipofectamine 
2000 (μl) 4 8 8 6 
Plasmid DNA 
(μg) 2 2 2 2 
 
Fixation 
In preparation for fixation the medium on cells in 6-well plates was changed 16-
20 h post-transfection.  Four hours later, at 24 h post-transfection, the medium was 
removed and each well was rinsed 3 times for 15 seconds with 2 ml D-PBS.  The cells 
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were fixed in 3.7% formaldehyde in D-PBS for 10 minutes.  The formaldehyde solution 
was removed and the cells were rinsed 3 times for 5 minutes with 2 ml D-PBS.  Next, the 
coverslips were mounted onto microscope slides in 8 μl Gel Mount with DAPI (4’, 6’-
diamidino-2-phenylindole; 0.5 mg/l).  After mounting, slides were stored at 4°C for at 
least 24 h before fluorescence microscopy.   
Fluorescence Microscopy Analysis 
The analysis of the distribution of fusion proteins in situ involved both imaging 
and scoring the cells.  Slides were examined using an Olympus BX60 fluorescence 
microscope.  DAPI stains double stranded DNA by attaching to AT clusters in the DNA 
minor groove (Kapuscinski et al., 1979).  The DAPI-DNA complex emits blue light (454 
nm) when excited by UV light (364 nm) and provides a reliable marker of the location 
and boundaries of a cell’s nucleus. Green fluorescent protein (GFP) emits green light 
(507 nm) when excited with blue light (488 nm).  Therefore, two excitation filters were 
employed: UV light showed the DAPI-stained nucleus and blue light allowed the GFP-
tagged fusion protein distribution to be analyzed.   
For HeLa, PC-12 and SH-SY5Y cells, two replicates of the individual domain 
transfection were scored and imaged.  For AML-12 cells, one individual domain 
transfection was analyzed.  For HeLa, AML-12, and SH-SY5Y cells, two replicates of the 
combination domain transfection were scored and imaged.  For PC-12 cells, three 
replicates of the combination domain transfection were analyzed.  For each experiment, 
between 75 and 150 cells were scored as having a predominantly nuclear, 
predominantly cytoplasmic, or whole cell distribution of the GFP-tagged fusion protein.  
Cells with a predominantly nuclear distribution had a brighter GFP fluorescence in the 
nucleus, compared to the cytoplasm (i.e. N>C).  Likewise, cells with a predominantly 
cytoplasmic distribution had a brighter GFP fluorescence in the cytoplasm, compared to 
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the nucleus (i.e. C>N).   Cells with a whole cell distribution were visually judged to have 
approximately equal fluorescence in the nucleus and the cytoplasm (i.e. N=C).  Both 
transfection with Lipofectamine 2000 and fixation with formaldehyde can compromise 
the integrity of a cell’s nucleus; consequently, only cells that were observed to have a 
healthy and intact nucleus were scored.  In addition, some cells had bright green foci 
that indicated aggregations of misfolded fusion proteins; these cells were excluded from 
scoring as well.  Scorings were not performed blind with respect to group.   
Black and white pictures of cells were taken with a Cooke SensiCamQE digital 
camera using IP Lab digital image capturing software.  IP Lab was further utilized to add 
color (GFP-green or DAPI-blue) to the black and white images, whereupon the files were 
further processed and organized into figures using Adobe Photoshop CS3 and Illustrator 
CS3.   
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Results 
 Nucleocytoplasmic shuttling of nuclear receptors is an additional cellular 
mechanism by which these transcription factors are regulated (Kaffman and Shea, 
1999).  TRα has been established as a shuttling protein through studies in Xenopus 
oocytes and interspecies heterokaryon assays (Bunn et al., 2001) and single species 
monokaryon assays (Grespin et al., 2008) using non-neuronal cell lines.  In these prior 
studies, TRα showed rapid import and export from the nucleus, but it was observed to 
have a predominantly nuclear distribution at steady-state.  However, it remains unclear 
the specific strength and activity of the import and export signals found in the functional 
domains of TRα.  Therefore, the shuttling properties of the functional domains of TRα 
were first studied in non-neuronal cell lines to establish a baseline for comparison.  In 
addition, given the critical role of TRα in the growth, development and function of the 
nervous system, it is of great interest to characterize the nuclear transport dynamics of 
TRα within neuronal cells.  To investigate the nucleocytoplasmic shuttling properties of 
TRα, individual and combination domain expression vectors containing GFP were 
transiently transfected into non-neuronal (HeLa and AML-12) and neuronal (PC-12 and 
SH-SY5Y) cell lines.  Cells were analyzed by fluorescence microscopy and the 
subcellular distribution of each GFP-tagged fusion protein was scored as predominantly 
nuclear, predominantly cytoplasmic or evenly distributed throughout the whole cell.   
Individual and Combination Domain Expression Vectors 
The individual domains of TRα include the A/B domain, the DNA-binding domain 
(DBD), the hinge domain (HD) and the ligand-binding domain (LBD) (Figure 2A).  As 
mentioned, TRα possesses the classic bipartite nuclear localization signal in the HD 
(Lee and Mahdavi, 1993) and a monopartite NLS in the A/B domain (M.S. Mavinakere 
and L.A. Allison, unpublished results).  Therefore, the A/B and HD fusion proteins were  
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Figure 2: TRα Individual and Combination Domain Fusion Proteins 
A) Individual functional domains: the A/B domain (A/B), the DNA-binding domain (DBD), 
the hinge domain (HD), and the Ligand-binding domain (LBD).  The GFP-GST-GFP tag 
increases the molecular mass of the fusion proteins such that they cannot passively 
diffuse through the nuclear pore complex, in addition to acting as a GFP reporter.   
B) The combinations included A/B-DBD, DBD-HD, DBD-HD-LBD, and HD-LBD, fused to 
GFP-GST-GFP, as in (A).   
C) The two controls used in each experiment were full-length TRα fused to a GFP 
reporter and GFP-GST-GFP alone.   
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predicted to have a predominantly nuclear intracellular distribution in the majority of 
cells.  Conversely, the DBD and LBD have no known nuclear import capabilities.  
Therefore, we predicted that the DBD and LBD fusion proteins would have a 
predominantly cytoplasmic intracellular distribution in the majority of cells.   
In addition to the individual domains, the localization of combination domain 
constructs was studied (Figure 2B).  The combination expression vectors included A/B-
DBD (1), DBD-HD (2), DBD-HD-LBD (3), and HD-LBD (4).  Combinations 1 and 2 were 
used to determine the effect of the DBD on the NLS activity of the A/B and HD 
individually.  The DBD is suspected to have a calreticulin binding site which would be 
expected to contribute to the nuclear export of the A/B and HD (Grespin et al., 2008).  
Alternatively, the DBD may increase the overall nuclear population of the A/B and Hinge 
domains by attaching to DNA and thereby increasing nuclear retention.   
Combinations 3 and 4 were used to investigate the effect of the LBD on the NLS 
activity of the HD.  As stated, the LBD contains multiple nuclear export sequences.  The 
level to which the NLS activity of the HD is affected by the LBD will depend on the 
strength of the NESs.  Two hypotheses are proposed: if the level of NES activity in the 
LBD is sufficient to override the NLS activity of the HD, then one would observe a 
cytoplasmic distribution of the fusion protein at steady-state.  Conversely, if the NESs 
are weaker than the HD NLS and/or masked by interactions of other proteins with the 
LBD, then one would observe a nuclear accumulation of combinations 3 and 4.   
Activity of Individual and Combination Domains in Non-Neuronal Cell Lines 
The individual and combination domain constructs were studied previously in 
HeLa cells by Dr. M. Mavinakere using a live-cell system.  In brief, Dr. Mavinakere found 
that the A/B and HD fusion proteins were predominantly present in the nucleus and that 
the DBD and LBD fusion proteins were predominantly present in the cytoplasm.  He 
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observed that combinations 1 and 2 localized mostly to the nucleus and that 
combinations 3 and 4 possessed a cytoplasmic distribution in the majority of cells.  Here, 
the initial experiments in HeLa cells were repeated to quantify these previous results.   
The A/B and Hinge Domain of TRα have NLS Activity in HeLa Cells 
To determine the nucleocytoplasmic shuttling properties of TRα in non-neuronal 
cells, individual domain expression vectors were first transiently transfected into HeLa 
cells.  Two replicate experiments were performed and the subcellular distributions of the 
fluorescently tagged fusion proteins were scored, averaged, and imaged (Figure 3).  In 
confirmation of Dr. Mavinakere's results, the A/B and HD constructs displayed a 
predominantly nuclear localization in a majority of cells, indicating that these regions 
have NLS activity.  However, the HD displayed a nuclear localization in a greater 
percentage of cells than the A/B domain.  There was an increase of 31 percentage 
points in the average of HD-expressing cells with a nuclear distribution compared with 
A/B-expressing cells (53% to 84%, Figure 3a).  In comparison, full-length GFP-TRα had 
a nuclear distribution in 98% of cells.  It is interesting that the cells expressing the A/B 
and HD constructs alone possessed 45% and 14%, respectively, fewer cells with nuclear 
distributions than full-length GFP-TRα.  These differences may provide evidence that 
neither domain is sufficient to lead to the full import of TRα. 
The DBD and LBD fusion proteins displayed a predominantly cytoplasmic 
distribution in the majority of cells.  The LBD fusion protein localized completely to the 
cytoplasm with an average of 98% of cells with a cytoplasmic distribution (Figure 3c,d).  
For the DBD fusion protein, only 86% of cells showed a cytoplasmic distribution.  The 
GFP-GST-GFP empty vector displayed a cytoplasmic distribution in 81% of cells.   
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Figure 3: The A/B and Hinge Domain of TRα have NLS Activity in HeLa Cells 
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Figure 3: The A/B and Hinge Domain of TRα have NLS Activity in HeLa Cells 
 
HeLa cells were transfected with TRα individual domain expression vectors and the 
subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Two 
replicate experiments were performed and the average distributions calculated.  
Complete cell counts and statistics are found in Appendix I.   
 
(a) This graph presents the differences in the average number of HeLa cells with nuclear 
distributions of the A/B, Hinge and GFP-TRα fusion proteins.  The A/B domain fusion 
protein has the weakest nuclear localization, at 53% of cells; the hinge domain fusion 
protein has a stronger nuclear localization, at 84% of cells; and full-length GFP-TRα has 
the greatest nuclear localization, at 98% of cells.  The green portion of the bar 
represents the percentage of cells with a whole cell distribution of the fusion protein.   
 
(b) Images of HeLa cells expressing the A/B, Hinge and GFP-TRα fusion proteins were 
captured with a fluorescence microscope and digital camera.  The slight presence of the 
A/B fusion protein in the cytoplasm is contrasted with the completely nuclear distribution 
of the hinge fusion protein. 
 
(c) This graph presents the differences in the average number of HeLa cells with 
cytoplasmic distributions of the DBD, LBD and GFP-GST-GFP fusion proteins.  GFP-
GST-GFP was the control and had a cytoplasmic distribution in 81% of cells.  The DBD 
and LBD fusion proteins possessed higher cytoplasmic distributions compared to the 
control, at 86% and 98% of cells, respectively.   
 
(d) Images of HeLa cells expressing the DBD, LBD and GFP-GST-GFP fusion proteins 
were captured with a fluorescence microscope and digital camera.  All three fusion 
proteins displayed a predominantly cytoplasmic distribution.  
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Activity of Combination Domains in HeLa Cells 
 To better understand the shuttling properties of TRα in non-neuronal cells, 
combination domain expression vectors were transiently transfected in HeLa cells.  Two 
replicate experiments were performed and the subcellular distributions of the fusion 
proteins were scored, averaged, and imaged (Figure 4).   
The DNA-Binding Domain of TRα has Opposite Effects on the Nuclear Localization of 
the A/B and Hinge Domains in HeLa Cells 
 Combinations 1 and 2 were used to assess the effect of the DNA-binding domain 
(DBD) on the NLS activity of the A/B and hinge domains in HeLa cells (Figure 4a,b).  
The presence of the DBD had opposite effects on the subcellular distributions of the A/B 
and HD fusion proteins (compare Figure 4a to Figure 3a).  The A/B-DBD fusion protein 
had a nuclear distribution in 78% of cells, an increase of 25 percentage points compared 
to the 53% of cells with a nuclear distribution of the A/B domain alone.  In contrast, the 
DBD-HD fusion protein had a nuclear distribution in 61% of cells, a decrease of 23 
percentage points compared to the 84% of cells with a nuclear distribution of the HD 
alone.  The differences seen in localization between the DBD-containing combination 
domains and the A/B and HD alone may indicate that the DBD is able to play multiple 
roles in nuclear transport.   
The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge 
Domain in HeLa Cells 
 Combinations 3 and 4 were used to assess the effect of the ligand-binding 
domain (LBD) on the NLS activity of the hinge domain in HeLa cells (Figure 4c,d).  
Strikingly, the localizations of combinations 3 and 4 were predominantly cytoplasmic in 
nearly all of the cells – a complete reversal compared to the predominantly nuclear 
localization in 84% of cells of the HD alone (compare Figure 4c to Figure 3a).  The  
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Figure 4: Activity of Combination Domains in HeLa Cells 
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Figure 4: Activity of Combination Domains in HeLa Cells 
 
HeLa cells were transfected with TRα combination domain expression vectors and the 
subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Two replicate 
experiments were performed and the average distributions calculated.  Complete cell counts 
and statistics are found in Appendix I.   
 
(a) The DNA-Binding Domain of TRα has Opposite Effects on the Nuclear Localization of the 
A/B and Hinge Domains in HeLa Cells: This graph presents the differences in the average 
number of HeLa cells with nuclear distributions of the A/B-DBD, DBD-Hinge and GFP-TRα 
fusion proteins.  The A/B-DBD fusion protein had a nuclear localization in 78% of cells, which 
represents an increase of 25 percentage points compared to the number of cells displaying a 
nuclear localization of the A/B domain alone.  The DBD-Hinge fusion protein had a nuclear 
localization in 61% of cells, which represents a decrease of 23 percentage points compared to 
the number of cells displaying a nuclear localization of the Hinge domain alone.   
 
(b) Images of HeLa cells expressing the A/B-DBD, DBD-Hinge and GFP-TRα fusion proteins 
were captured with a fluorescence microscope and digital camera.  The slight presence of the 
combination domain fusion proteins in the cytoplasm is contrasted with the full nuclear 
localization of the GFP-TRα control.   
 
(c) The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge Domain 
in HeLa Cells: This graph presents the differences in the average number of HeLa cells with 
cytoplasmic distributions of the DBD-HD-LBD, HD-LBD and GFP-GST-GFP fusion proteins.  In 
contrast with the nuclear localization of the Hinge domain alone (Figure 3a, b), LBD-containing 
combination domain constructs are completely cytoplasmic.   
 
(d) Images of HeLa cells expressing the DBD-HD-LBD, HD-LBD and GFP-GST-GFP fusion 
proteins were captured with a fluorescence microscope and digital camera.  The completely 
cytoplasmic distributions of the LBD-containing combination domains are a stark contrast to the 
predominantly nuclear distribution of the Hinge domain fusion protein (Figure 3b) 
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localization of combinations 3 and 4 was cytoplasmic in 91% and 93% of cells respectively, only 
slightly fewer than the percentage of cells with a cytoplasmic distribution of the LBD alone.  
These data provide compelling evidence that the LBD possesses strong NES activity.   
The A/B and Hinge Domains of TRα have Strong NLS Activity in AML-12 Cells 
To further characterize the nucleocytoplasmic shuttling properties of TRα in non-
neuronal cells, individual domain expression vectors were transiently transfected into AML-12 
cells.  Due to time constraints, only one experiment was performed and the subcellular 
distributions of the fusion proteins were scored and imaged (Figure 5).  In these cells, A/B and 
HD fusion proteins had a predominantly nuclear localization in the majority of cells, indicating 
NLS activity.  Compared to HeLa cells, the percentages of cells with nuclear distributions of A/B 
and HD fusion proteins were much greater in AML-12 cells (compare Figure 5a to Figure 3a).  
The number of cells with a nuclear distribution of the A/B fusion protein increased by 35 
percentage points to an average of 89% of cells with a nuclear distribution.  The number of cells 
with a nuclear distribution of the HD fusion protein increased by 15 percentage points to an 
average of 99% of cells with a nuclear distribution.  Full-length GFP-TRα had a nuclear 
distribution in 99% of cells.  The DBD and LBD fusion proteins were completely cytoplasmic in 
99% and 100% of cells, respectively (Figure 5c,d).   
As in HeLa cells, the DBD and LBD had a cytoplasmic distribution in a greater number of 
cells than the GFP-GST-GFP empty vector, which displayed a cytoplasmic distribution in 89% of 
cells.   
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Figure 5: The A/B and Hinge Domain of TRα have Strong NLS Activity in AML-12 Cells 
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Figure 5: The A/B and Hinge Domain of TRα have Strong NLS Activity in AML-12 
Cells 
 
AML-12 cells were transfected with TRα individual domain expression vectors and the 
subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Due to time 
constraints, the experiment was performed only once.  Complete cell counts and 
statistics are found in Appendix I. 
 
(a) This graph presents the differences in the average number of AML-12 cells with 
nuclear distributions of the A/B, Hinge and GFP-TRα fusion proteins.  The tiny red bar in 
the A/B column represents 2% of cells that were scored as having a predominantly 
cytoplasmic distribution of the A/B fusion protein.  In the great majority of AML-12 cells, 
A/B and HD fusion proteins strongly localized to the nucleus.  The A/B domain fusion 
protein shows a nuclear distribution in 89% of cells and the HD fusion protein displays a 
nuclear distribution in 99% of cells.  GFP-TRα was localized in the nucleus in 99% of 
cells.     
 
(b) Images of AML-12 cells expressing the A/B, Hinge and GFP-TRα fusion proteins 
were captured with a fluorescence microscope and digital camera.  There is a slight 
presence of the A/B domain fusion protein in the cytoplasm, in contrast to the complete 
nuclear localization of the Hinge and GFP-TRα fusion proteins.  However, each cell 
shown was scored as predominantly nuclear.   
 
(c) This graph presents the differences in the average number of AML-12 cells with 
cytoplasmic distributions of the DBD, LBD and GFP-GST-GFP fusion proteins.  As in 
HeLa cells, both the DBD and LBD fusion proteins had a cytoplasmic distribution in a 
greater percentage of cells that GFP-GST-GFP alone.   
 
(d) Images of AML-12 cells expressing the DBD, LBD and GFP-GST-GFP fusion 
proteins were captured with a fluorescence microscope and digital camera.  All three 
fusion proteins displayed a predominantly cytoplasmic distribution.  
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Activity of Combination Domains in AML-12 Cells 
To better understand the shuttling properties of TRα in non-neuronal tissues, 
combination domain expression vectors were transiently transfected in AML-12 cells.  
Two replicate experiments were performed and the subcellular distributions of the fusion 
proteins were scored, averaged, and imaged (Figure 6).   
The DNA-Binding Domain of TRα Leads to a Decrease in Nuclear Localization of the 
Hinge Domain in AML-12 Cells 
Combinations 1 and 2 were used to assess the effect of the DNA-binding domain 
(DBD) on the NLS activity of the A/B and hinge domains in AML-12 cells (Figure 6a,b).  
The addition of the DBD to the A/B domain in combination 1 led to a very slight increase 
(2 percentage points) in the number of cells with a nuclear distribution of the fusion 
protein.  A greater change is observed with the addition of the DBD to the HD in 
combination 2, which correlated with an overall decrease in the percentage of cells 
displaying a nuclear localization of the fusion protein, as in HeLa cells (compare Figure 
6a to Figure 5a).  The DBD-HD fusion protein had a nuclear localization in 84% of cells, 
a decrease of 15 percentage points compared to the 99% of cells with a nuclear 
distribution of the HD alone.   
The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge 
Domain in AML-12 Cells 
Combinations 3 and 4 were used to assess the effect of the ligand-binding domain (LBD) 
on the NLS activity of the hinge domain in AML-12 cells (Figure 6c,d).  As in HeLa cells, 
the addition of the LBD to the HD in combinations 3 and 4 completely reversed the 
intracellular localization of the HD (compare Figure 6c to Figure 5a), indicating strong 
NES activity in the LBD.  Compared to the 100% of cells with a cytoplasmic distribution  
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Figure 6: Activity of Combination Domains in AML-12 Cells 
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Figure 6: Activity of Combination Domains in AML-12 Cells 
 
AML-12 cells were transfected with TRα combination domain expression vectors and the 
subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Two 
replicate experiments were performed and average distributions calculated.  Complete 
cell counts and statistics are found in Appendix I. 
 
(a) The DNA-Binding Domain of TRα Leads to a Decrease in the Nuclear Localization of 
the Hinge Domains in AML-12 Cells: This graph presents the differences in the average 
number of AML-12 cells with nuclear distributions of the A/B-DBD, DBD-Hinge and GFP-
TRα fusion proteins.  The A/B-DBD fusion protein had a nuclear distribution in 91% of 
cells, which is only an increase of 2 percentage points over the nuclear distribution of the 
A/B domain alone.  The DBD-HD fusion protein had a nuclear distribution in 84% of 
cells, a decrease of 15 percentage points compared to the nuclear distribution of the 
Hinge domain alone.   
 
(b) Images of AML-12 cells expressing the A/B-DBD, DBD-Hinge and GFP-TRα fusion 
proteins were captured with a fluorescence microscope and digital camera.  A/B-DBD, 
DBD-HD and GFP-TRα fusion proteins all displayed a predominantly nuclear distribution 
in AML-12 cells.   
 
(c) The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge 
Domain in AML-12 Cells: This graph presents the differences in the average number of 
AML-12 cells with cytoplasmic distributions of the DBD-HD-LBD, HD-LBD and GFP-
GST-GFP fusion proteins.  The DBD-HD-LBD fusion protein displayed a cytoplasmic 
distribution in 85% of cells.  The HD-LBD fusion protein displayed a cytoplasmic 
distribution in 94% of cells.  The presence of the LBD completely reverses the nuclear 
localization of the Hinge domain alone (Figure 5a, b).   
 
(d) Images of AML-12 cells expressing the DBD-HD-LBD, HD-LBD and GFP-GST-GFP 
fusion proteins were captured with a fluorescence microscope and digital camera.  Like 
HeLa cells, the cytoplasmic localization of the LBD-containing combination domains is in 
stark contrast to the completely nuclear localization of the Hinge domain alone (Figure 
5a, b).   
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of the LBD alone, the cytoplasmic distributions of the DBD-HD-LBD and HD-LBD 
combinations were slightly decreased, at 85% and 94% of cells, respectively.  This may 
indicate that the HD is functional in targeting the nucleus, but that the strength of NES 
activity in the LBD overrides any efforts at nuclear retention. 
Activity of Individual and Combination Domains in Neuronal Cell Lines 
 TRα exerts critical regulatory control over the transcription of genes involved in 
various aspects of central nervous system growth, development and function (Williams, 
2008).  Nucleocytoplasmic shuttling is an important mechanism by which transcription 
factors including TR are regulated; however, the complete physiological significance of 
shuttling is unknown (Bunn et al., 2001).  Therefore, it was hypothesized that there might 
exist cell-type specific differences in the shuttling of TRα that regulate specific aspects of 
TRα function.  Here, to begin to test this hypothesis, the nuclear transport dynamics of 
the individual and combination domains of TRα were investigated in PC-12 and SH-
SY5Y neuronal cell lines. 
The A/B Domain of TRα Shows Markedly Decreased NLS Activity Compared to the 
Hinge Domain in PC-12 Cells 
 To understand the nucleocytoplasmic shuttling properties of TRα in neuronal cell 
lines, individual domains were first transiently transfected into PC-12 cells.  Three 
replicate experiments were performed and the subcellular distributions of the 
fluorescently tagged fusion proteins were scored, averaged, and imaged (Figure 7).  The 
A/B and HD displayed NLS activity; however, the average number of cells showing a 
nuclear distribution of the A/B domain was markedly decreased compared to the number 
of cells showing a nuclear distribution of the HD (Figure 7a).  The HD had a nuclear  
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Figure 7: The A/B Domain of TRα Shows Markedly Decreased NLS 
Activity Compared to the Hinge Domain in PC-12 Cells 
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Figure 7: The A/B Domain of TRα Shows Markedly Decreased NLS Activity 
Compared to the Hinge Domain in PC-12 Cells 
 
PC-12 cells were transfected with TRα individual domain expression vectors and the 
subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Three 
replicate experiments were performed and average distributions calculated.  Complete 
cell counts and statistics are found in Appendix I. 
 
(a) This graph presents the differences in the average number of PC-12 cells with 
nuclear distributions of the A/B, Hinge and GFP-TRα fusion proteins.  There was a 
marked difference between the A/B and Hinge domain nuclear localization in PC-12 
cells.  The A/B domain displayed a nuclear localization in 19% of cells, a cytoplasmic 
distribution in 6% of cells, and a whole cell distribution in 75% of cells.  The Hinge 
domain displayed a nuclear distribution in 78% of cells, a cytoplasmic distribution in 3% 
of cells, and a whole cell distribution in 19% of cells.  Compared to non-neuronal cells, 
the A/B domain shifted slightly in distribution to the cytoplasm.  GFP-TRα displayed a 
nuclear distribution in 89% of cells and a whole cell distribution in 11% of cells.   
 
(b) Images of PC-12 cells expressing the A/B, Hinge and GFP-TRα fusion proteins were 
captured with a fluorescence microscope and digital camera.  The whole cell distribution 
of the A/B fusion protein is contrasted with the predominantly nuclear distributions of the 
Hinge and GFP-TRα fusion proteins.   
 
(c) This graph presents the differences in the average number of PC-12 cells with 
cytoplasmic distributions of the DBD, LBD and GFP-GST-GFP fusion proteins.  The 
DBD fusion protein displayed a cytoplasmic localization in 88% of cells and the LBD 
displayed a cytoplasmic localization in 99% of cells.  The GFP-GST-GFP control 
displayed a cytoplasmic distribution in 89% of cells.   
 
(d) Images of PC-12 cells expressing the DBD, LBD and GFP-GST fusion proteins were 
captured with a fluorescence microscope and digital camera.  All three fusion proteins 
displayed a predominantly cytoplasmic distribution.   
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distribution in 78% of cells whereas the A/B domain had a nuclear distribution in only 
19% of cells, demonstrating a decrease of 59 percentage points in the number of cells 
with a nuclear localization of the fusion protein.   
In comparison to the non-neuronal cell lines, there are fewer PC-12 cells with a 
nuclear localization of the HD (78% of PC-12, 84% of HeLa, 99% of AML-12); and, there 
are a slightly greater number of cells with a predominantly cytoplasmic distribution (3%).  
The A/B domain displayed a more dramatic shift to the cytoplasm in PC-12 cells, mostly 
through an increase in the number of cells with a whole cell distribution of the fusion 
protein.  An average of 75% of A/B-expressing PC-12 cells had a whole cell distribution, 
an increase of 28 percentage points over the 47% of A/B-expressing HeLa cells with a 
whole cell distribution and an increase of 66 percentage points over the 9% of A/B 
expressing AML-12 cells with a whole cell distribution.  An average of 6% of PC-12 cells 
had a predominantly cytoplasmic distribution of the A/B domain fusion protein. 
 The DBD and LBD had a primarily cytoplasmic distribution (Figure 7c,d), 
comparable to the results in non-neuronal cell lines.  The DBD was cytoplasmic in 88% 
of cells and the LBD was cytoplasmic in 99% of cells.  The GFP-GST-GFP empty vector 
was cytoplasmic in 89% of cells.   
Activity of Combination Domains in PC-12 Cells 
 To better understand the shuttling properties of TRα in neuronal tissues, 
combination domain expression vectors were transiently transfected in PC-12 cells.  Two 
replicate experiments were carried out and the subcellular distributions of the fusion 
proteins scored, averaged, and imaged (Figure 8).   
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Figure 8: Activity of Combination Domains in PC-12 Cells 
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Figure 8: Activity of Combination Domains in PC-12 Cells 
 
PC-12 cells were transfected with TRα combination domain expression vectors and the 
subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Two 
replicate experiments were performed and average distributions calculated.  Complete 
cell counts and statistics are found in Appendix I. 
 
(a) The DNA-Binding Domain of TRα has Opposite Effects on the Nuclear Localization 
of the A/B and Hinge Domains in PC-12 Cells: This graph presents the differences in 
average number of PC-12 cells with nuclear distributions of the A/B-DBD, DBD-Hinge 
and GFP-TRα fusion proteins.  The presence of the DBD led to an increase in the 
nuclear localization of the A/B domain and decrease in the nuclear localization of the 
Hinge domain, compared to the A/B and Hinge domains alone.  The A/B-DBD fusion 
protein had a nuclear distribution in 38% of cells, a cytoplasmic distribution in 11% of 
cells, and a whole cell distribution in 52% of cells.  The DBD-HD fusion protein had a 
nuclear distribution in 25% of cells, a cytoplasmic distribution in 21% of cells, and a 
whole cell distribution in 54% of cells.  GFP-TRα had a nuclear distribution in 91% of 
cells. 
 
(b) Images of PC-12 cells expressing the A/B-DBD, DBD-Hinge and GFP-TRα fusion 
proteins were captured with a fluorescence microscope and digital camera.  The image 
of the A/B-DBD construct shows predominantly nuclear distributions whereas the image 
of the DBD-HD gives an example of three cells with whole cell distributions of the fusion 
protein.  GFP-TRα shows a nuclear control.   
 
(c) The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge 
Domain in PC-12 Cells: This graph presents the differences in average cytoplasmic 
distributions between the DBD-HD-LBD, HD-LBD and GFP-GST-GFP fusion proteins in 
PC-12 cells.  The DBD-HD-LBD and HD-LBD fusion proteins displayed cytoplasmic 
distributions in 98 and 100% of cells, respectively.  As in HeLa and AML-12 cells, the 
presence of the LBD completely reverses the nuclear localization of the hinge domain 
alone (Figure 7a, b).   
 
(d) Images of PC-12 cells expressing the DBD-HD-LBD, HD-LBD and GFP-GST-GFP 
fusion proteins were captured with a fluorescence microscope and digital camera.  Like 
HeLa and AML-12 cells, the cytoplasmic localization of the LBD-containing combination 
domains is a stark contrast to the completely nuclear localization of the Hinge domain 
alone (Figure 7a, b).   
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The DNA-Binding Domain of TRα has Opposite Effects on the Nuclear Localization of 
the A/B and Hinge Domains in PC-12 Cells 
 Combinations 1 and 2 were used to assess the effect of the DNA-binding domain 
(DBD) on the NLS activity of the A/B and hinge domains (HD) in PC-12 cells (Figure 
8a,b).  As in HeLa and AML-12 cells, the presence of the DBD had opposite effects on 
the subcellular distributions of the A/B and Hinge domain constructs (compare Figure 8a 
to Figure 7a).  The A/B-DBD combination had a nuclear distribution in 38% of cells, an 
increase of 19 percentage points compared to the 19% of cells with a nuclear distribution 
of the A/B domain alone.  Conversely, the DBD-HD combination had a nuclear 
distribution in 25% of cells, a decrease of 53 percentage points compared to the 78% of 
cells with a nuclear distribution of the HD alone.  These results mirror what was 
observed in HeLa cells, providing additional evidence that the DBD affects nuclear 
transport in a context-specific manner.   
However, in contrast to the non-neuronal cells, the increase in the number of A/B-
DBD-expressing cells with a nuclear distribution was curiously accompanied by an 
increase in the number of these cells with a cytoplasmic localization (Figure 8a, red 
bars).  The A/B-DBD combination had a cytoplasmic distribution in 11% of cells, an 
increase of 5 percentage points compared to the 6% of cells with a cytoplasmic 
distribution of the A/B domain alone.  Likewise, the decrease in the number of DBD-HD-
expressing cells with a nuclear distribution was accompanied by an increase in the 
number of these cells with a predominantly cytoplasmic localization.  The DBD-HD 
combination had a cytoplasmic distribution in 21% of cells, an increase of 18 percentage 
points compared to the 3% of cells with a cytoplasmic distribution of the HD alone.  
Since there were little to no cells with predominantly cytoplasmic distributions of 
combinations 1 and 2 in non-neuronal cells (there were cells with a whole cell 
distribution), this shift to the cytoplasm in neuronal cells provides evidence that there are 
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differences in the cellular conditions regulating the shuttling of TRα between non-
neuronal and neuronal cell lines.   
The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge 
Domain in PC-12 Cells 
 Combination domains 3 and 4 were used to assess the effect of the ligand-
binding domain (LBD) on the NLS activity of the hinge domain (HD) in PC-12 cells 
(Figure 8c,d).  As in the non-neuronal cell lines, these constructs were completely 
cytoplasmic in PC-12 cells.  The DBD-HD-LBD fusion protein had a cytoplasmic 
distribution in 98% of cells and the HD-LBD fusion protein had a cytoplasmic distribution 
in 100% of cells.  These percentages are directly comparable to the 99% of cells with a 
cytoplasmic distribution of the LBD alone.  These results provide evidence that the LBD 
possesses strong NES-activity in neuronal cells, in addition to non-neuronal cells. 
 
The A/B Domain of TRα Shows Markedly Reduced NLS Activity Compared to the 
Hinge Domain in SH-SY5Y Cells 
 To further investigate the shuttling properties of TRα in neuronal cells, individual 
domain expression vectors were transiently transfected into SH-SY5Y cells.  Two 
replicate experiments were performed and the subcellular distributions of the fusion 
proteins were scored, averaged, and imaged (Figure 9).  The A/B and HD both displayed 
NLS activity; however, as in PC-12 cells, the nuclear localization of the A/B domain was 
markedly reduced compared to the HD (Figure 9a).  The HD had a nuclear distribution in 
72% of cells whereas the A/B domain had a nuclear distribution in only 23% of cells, 
demonstrating a decrease of 49 percentage points in the number of cells with a nuclear 
distribution.  To compare, PC-12 cells had a 59 percentage point difference in the  
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Figure 9: The A/B Domain of TRα Shows Markedly Decreased NLS 
Activity Compared to the Hinge Domain in SH-SY5Y Cells 
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Figure 9: The A/B Domain of TRα Shows Markedly Decreased NLS Activity 
Compared to the Hinge Domain in SH-SY5Y Cells 
 
SH-SY5Y cells were transfected with TRα individual domain expression vectors and the 
subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Two 
replicate experiments were performed and average distributions calculated.  Complete 
cell counts and statistics are found in Appendix I. 
 
(a)  This graph presents the differences in the average number of SH-SY5Y cells with 
nuclear distributions of the A/B, Hinge and GFP-TRα fusion proteins.  Like PC-12 cells, 
there was a marked difference between the A/B and Hinge domain nuclear localization 
in SH-SY5Y cells.  The A/B domain displayed a nuclear distribution in 23% of cells, a 
cytoplasmic distribution in 15% of cells, and a whole cell distribution in 62% of cells.  The 
Hinge domain displayed a nuclear distribution in 72% of cells, a cytoplasmic distribution 
in 3% of cells, and a whole cell distribution in 24% of cells.  The A/B domain showed a 
shift in distribution to the cytoplasm compared with non-neuronal cell lines.   
 
(b)  Images of SH-SY5Y cells expressing the A/B, Hinge and GFP-TRα fusion proteins 
were captured with a fluorescence microscope.  The whole cell distribution of the A/B 
domain is contrasted with the predominantly nuclear localization of the Hinge and GFP-
TRα fusion proteins.   
 
(c)  This graph presents the differences in the average number of SH-SY5Y cells with 
cytoplasmic distributions of the DBD, LBD and GFP-GST-GFP fusion proteins.  The 
DBD fusion protein displayed a cytoplasmic localization in 93% of cells and the LBD 
displayed a cytoplasmic localization in 98% of cells.  The GFP-GST-GFP control 
displayed a cytoplasmic distribution in 88% of cells. 
 
(d)  Images of SH-SY5Y cells expressing the DBD, LBD and GFP-GST fusion proteins 
were captured with a fluorescence microscope.  All three fusion proteins displayed a 
predominantly cytoplasmic distribution.   
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number of cells displaying a nuclear distribution of the A/B and HD, whereas HeLa and 
AML-12 cells had 31 and 10 percentage point differences, respectively.  While each cell 
line is different, there may be an overall  greater difference in the number of cells with 
nuclear distributions of the A/B and HD in neuronal cells compared to non-neuronal cells.  
These observations suggest cell-type specific differences in the regulation of nuclear 
transport between non-neuronal and neuronal cell lines.   
In further comparison to non-neuronal cells, the HD had a nuclear distribution in 
a lower percentage of SH-SY5Y cells (72% of SH-SY5Y, 84% of HeLa, 99% of AML-12).  
The HD also shifted slightly to the cytoplasm, since 3% of SH-SY5Y cells had a 
predominantly cytoplasmic distribution of the fusion protein.  Like PC-12 cells, the A/B 
domain in SH-SY5Y cells shifted a greater percentage of cells to the cytoplasm.   The 
A/B domain had a predominantly cytoplasmic distribution in 15% of cells (Figure 9a, red 
bars).  Interestingly, in a very small percentage of cells (1%) GFP-TRα showed a 
cytoplasmic distribution, although it was predominantly nuclear in the majority of cells 
(92%).   
 The DBD and LBD were predominantly located in the cytoplasm in SH-SY5Y 
cells (Figure 9c,d).  The DBD had a cytoplasmic distribution in 93% of cells and the LBD 
had a cytoplasmic distribution in 98% of cells.  The GFP-GST-GFP empty vector had a 
cytoplasmic distribution in 88% of cells. 
Activity of Combination Domains in SH-SY5Y Cells 
 To better understand the shuttling properties of TRα in neuronal cells, 
combination domain expression vectors were transiently transfected in SH-SY5Y cells.  
Two replicate experiments were performed and the subcellular distributions of the fusion 
proteins were scored, averaged, and imaged (Figure 10).   
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Figure 10: Activity of Combination Domains in SH-SY5Y Cells 
 
 
(a)             (b) 
 
 
(c)             (d) 
 
  
0
10
20
30
40
50
60
70
80
90
100
A/B-DBD DBD-HD GFP-TR
P
er
ce
nt
 o
f C
el
ls
Nuclear Cytoplasmic Whole Cell
0
10
20
30
40
50
60
70
80
90
100
DBD-HD-LBD HD-LBD GFP-GST-GFP
P
er
ce
nt
 o
f C
el
ls
Nuclear Cytoplasmic Whole Cell
46 
 
Figure 10: Activity of Combination Domains in SH-SY5Y Cells 
 
SH-SY5Y cells were transfected with TRα combination domain expression vectors and 
the subcellular distributions of the fusion proteins were scored as predominantly nuclear, 
predominantly cytoplasmic, or evenly distributed throughout the whole cell.  Two 
replicate experiments were performed and average distributions calculated.  Complete 
cell counts and statistics are found in Appendix I. 
 
(a) The DNA-Binding Domain of TRα has Opposite Effects on the Nuclear Localization 
of the A/B and Hinge Domains in SH-SY5Y Cells: This graph presents the differences in 
the average number of SH-SY5Y cells with nuclear distributions of the A/B-DBD, DBD-
Hinge and GFP-TRα fusion proteins.  Like HeLa and PC-12 cells, the presence of the 
DBD led to an increase in the nuclear localization of the A/B domain and decrease in the 
nuclear localization of the Hinge domain, compared to the A/B and Hinge domains 
alone.  The A/B-DBD fusion protein had a nuclear distribution in 45% of cells, a 
cytoplasmic distribution in 10% of cells, and a whole cell distribution in 44% of cells.  The 
DBD-HD fusion protein had a nuclear distribution in 28% of cells, a cytoplasmic 
distribution in 13% of cells, and a whole cell distribution in 59% of cells.  GFP-TRα had a 
nuclear distribution in 92% of cells. 
 
(b) Images of SH-SY5Y cells expressing the A/B-DBD, DBD-Hinge and GFP-TRα fusion 
proteins were captured with a fluorescence microscope and digital camera.  The image 
of the A/B domain represents a predominantly nuclear distribution whereas the image of 
the Hinge domain shows two cells with whole cell distributions.  GFP-TRα displays a 
predominantly nuclear distribution in two cells.   
 
(c) The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge 
Domain in SH-SY5Y Cells: This graph presents the differences in the average number of 
SH-SY5Y cells with cytoplasmic distributions of the DBD-HD-LBD, HD-LBD and GFP-
GST-GFP fusion proteins.  The DBD-HD-LBD and HD-LBD fusion proteins displayed 
cytoplasmic distributions in 93 and 96% of cells, respectively.  As in HeLa, AML-12 and 
PC-12 cells, the presence of the LBD completely reverses the nuclear localization of the 
hinge domain alone (Figure 9a, b).   
 
(d) Images of SH-SY5Y cells expressing the DBD-HD-LBD, HD-LBD and GFP-GST-
GFP fusion proteins were captured with a fluorescence microscope and digital camera.  
Like HeLa, AML-12 and PC-12 cells, the cytoplasmic localization of the DBD-containing 
combination domain constructs is a complete reversal of the nuclear localization of the 
Hinge domain alone (Figure 9a, b).   
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The DNA-Binding Domain of TRα has Opposite Effects on the Localization of the A/B 
and Hinge Domains in SH-SY5Y Cells 
 Combinations 1 and 2 were used to assess the effect of the DNA-binding domain 
(DBD) on the NLS activity of the A/B and hinge domain (HD) in SH-SY5Y cells (Figure 
10a,b).  As in HeLa and PC-12 cells, the presence of the DBD had opposite effects on 
the subcellular distributions of the A/B and HD domain constructs (compare Figure 10a 
to Figure 9a).  The A/B-DBD combination domain construct had a nuclear distribution in 
45% of cells, an increase of 22 percentage points compared to the 23% of cells with a 
nuclear distribution of the A/B domain alone.  The DBD-HD construct had a nuclear 
distribution in 28% of cells, a decrease of 44 percentage points compared to the 72% of 
cells with a nuclear distribution of the HD alone.  This evidence further indicates that the 
DBD may affect multiple aspects of nuclear transport.   
The Ligand-Binding Domain of TRα Reverses the Nuclear Localization of the Hinge 
Domain in SH-SY5Y Cells 
 Combinations 3 and 4 were used to assess the effect of the ligand-binding 
domain (LBD) on the NLS activity of the hinge domain (HD) in SH-SY5Y cells (Figure 
10c,d).  As in HeLa, AML-12 and PC-12 cells, these constructs were predominantly 
cytoplasmic in nearly all SH-SY5Y cells scored.  The DBD-HD-LBD combination had a 
cytoplasmic distribution in 93% of cells and the HD-LBD construct had a cytoplasmic 
distribution in 96% of cells.  Taken together with the data from HeLa, AML-12 and PC-12 
cell lines, these results indicate that the LBD has strong export activity.   
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Discussion 
 The data from our study of the localization of TRα individual and combination 
domains in neuronal and non-neuronal cell lines showed that the A/B and hinge domains 
have NLS activity in all cell lines tested.  The hinge domain was localized to the nucleus 
in a greater percentage of cells overall, compared to the A/B domain, suggesting that the 
hinge domain NLS may be a stronger signal for import.  However, the data from the 
DBD-HD-LBD combination domain suggest that both NLSs are required for the 
predominantly nuclear localization of full-length TRα.  Additionally, this combination 
domain showed that the ligand-binding domain confers strong nuclear export activity, in 
confirmation of the prediction of multiple NES in this region (M.S. Mavinakere and L.A. 
Allison, unpublished results).  Other combination domain constructs showed that the 
DNA-binding domain had differential effects on the nuclear localization of the A/B and 
hinge domains.  In particular, the decrease in hinge domain nuclear localization with the 
addition of the DBD was not expected, given that it was also seen to contain the stronger 
signal for import.  Throughout the study, cell type-specific differences in localization were 
observed between neuronal and non-neuronal cell lines.  The most distinct difference 
was the increase in the shift to the cytoplasm of the A/B and hinge domain constructs in 
neuronal cells.   
 Taken together, these data suggest a number of conclusions about the 
nucleocytoplasmic shuttling of TRα.  First, it appears that the A/B and hinge domain 
NLSs act cooperatively in the import of TRα and that these NLSs access more than one 
import pathway.  Varying import efficiency of the individual pathways could explain the 
apparent differences in the NLS activity of the A/B and hinge domain.  Second, our 
observations reveal the primary function of the ligand-binding domain in the export of 
TRα.  A role for NES-masking in the ligand-binding domain is suggested to account for 
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the hormone-induced nuclear accumulation of TRα and TRβ observed by other groups 
(Zhu et al., 1998; Bunn et al., 2001).  Finally, the cell-type specific differences in 
localization indicate that the shuttling of TRα may be differentially regulated across cell 
lines and tissue types.  Further research into the shuttling dynamics of TRα in the 
nervous system is warranted to determine if compartmentalization of TRα is a principle 
mechanism by which neuronal cells control specific events, such as differentiation.   
Cooperative Activity of the A/B and Hinge Domain NLS in the Import of TRα 
Data from the individual and combination domain constructs indicate that the A/B 
and hinge domain NLSs work cooperatively to achieve the overall nuclear subcellular 
distribution of full-length TRα.  Individually, the A/B and hinge domains targeted GFP-
GST-GFP to the nucleus in non-neuronal and neuronal cell lines.  In all cell lines, the 
hinge domain was localized to the nucleus in a greater percentage of cells compared to 
the A/B domain, which suggests that the hinge domain NLS may be the primary signal 
for import of TRα.  However, in HeLa, PC-12 and SH-SY5Y cell lines the A/B and the 
hinge domain displayed less overall nuclear character than full-length GFP-TRα, which 
suggests that neither domain alone is sufficient for the full import of TRα.  To study this 
further, we used the DBD-HD-LBD combination domain construct.  Previous research 
has shown that a TRα mutant lacking only the hinge domain localized completely to the 
cytoplasm in monkey kidney cells (Lee and Mahdavi, 1993).  We observed that the DBD-
HD-LBD fusion protein localized exclusively to the cytoplasm in all four cell lines studied.  
From these data we conclude that neither the A/B nor the hinge domain alone is 
sufficient to localize TRα to the nucleus.  Taken together, these results suggest that the 
A/B and hinge domain NLS act cooperatively in the import of TRα.   
We have confirmed the activity of two nuclear localization sequences in TRα.  It 
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should be mentioned that other proteins possess more than one NLS, including 
fibroblast growth factor-1 (FGF-1) (Wesche et al., 2005), the tumor suppressor p53 
(Shaulsky et al., 1990), the phosphatidylserine receptor (Cui et al., 2004), the 
glucocorticoid receptor (GR) (Picard and Yamamato, 1987),  the vitamin-D receptor 
(VDR) (Hsieh et al., 1998; Michigami et al., 1999), and the androgen receptor (AR) 
(Kaku et al., 2008).  A cooperative effect of the multiple NLSs was suggested to explain 
the import of FGF-1, p53, GR and AR.  Mutations in either of the two NLSs of FGF-1 
reduced transport of the growth factor to the nucleus, from which the authors infer that 
both NLSs are required for efficient nuclear import (Wesche et al., 2005).  The p53 tumor 
suppressor protein possesses three NLSs, with the most N-terminal signal being the 
primary mediator of nuclear localization.  However, since none of the individual NLSs are 
able to confer an exclusively nuclear distribution of p53, the researchers suggest that the 
complete nuclear localization of p53 requires the additive activity of all three NLSs in the 
cell (Shaulsky et al., 1990).  The glucocorticoid receptor contains two NLS, denoted NL1 
and NL2.  NL1 is just C-terminal to the DNA-binding domain in the hinge region and NL2 
is within the ligand-binding domain (Picard and Yamamato, 1987).  Full nuclear 
localization of GR is hormone dependent, and it has been shown that NL1 and NL2 are 
repressed in the absence of ligand (Cadepond et al., 1992).  In the same study, hormone 
binding activated NL2 but alone it was unable to fully target GR to the nucleus.  An 
unrepressed NL1 along with the activated NL2 was required to sustain a full nuclear 
localization (Cadepond et al., 1992).  The androgen receptor was found to contain three 
NLSs, one in the A/B domain, one in the DNA-binding domain and one in the ligand-
binding domain.  Through the observation of the localization of various AR mutants and 
domain constructs, researchers concluded that the import of AR is controlled by a 
dynamic interplay between the multiple NLSs (Kaku et al., 2008).  In summary, many 
proteins, including other nuclear receptors, utilize more than one NLS to efficiently gain 
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entry into the nucleus.   
To study the dependence of TRα on the individual NLS in the A/B and hinge 
domains, it would be useful to observe the localization of TRα mutants with various 
combinations of point mutations in the NLS of the A/B and hinge domains.  Previous 
research on TRα NLS has focused on the hinge domain of TRα.  Basic to neutral amino 
acid substitutions have been studied in the hinge domain (Lee and Mahdavi, 1993), but 
to date no research has isolated the NLS in the A/B domain.  Therefore, mutational 
analysis of the A/B domain NLS is necessary to reach a better understanding of the 
import of TRα.  Further research into the cooperative action of the A/B and hinge domain 
NLSs in TRα would greatly increase our understanding of the specific mechanisms for 
the import of TRα.   
Multiple Pathways for the Import of TRα 
The principal means by which multiple NLSs act cooperatively to achieve import 
may be through different pathways for the import of TRα.  Separate routes into the 
nucleus arise through the binding of NLSs to a variety of import factors.  Research has 
shown that a wide array of proteins with one or more NLS have the capacity to interact 
with a variety of importins.  These proteins include, but are not limited to, the viral 
proteins Rev of HIV-1 (Arnold et al., 2006) and protein VII of the adenovirus core 
(Wodrich et al., 2006), the transcription factors Stat3 (Ma and Cao, 2006) and c-Jun 
(Waldmann et al., 2007), the ribosomal protein L23a (Jäkel and Görlich , 1998) and the 
previously mentioned nuclear receptors GR (Freedman and Yamamoto, 2004) and AR 
(Kaku et al., 2008).  Notably, a single NLS of these proteins may be recognized by a 
number of import receptors.  Conversely, a single import receptor can bind a diverse set 
of chemically distinct NLSs.   
Multiple import pathways can arise at different levels in the import process.  First, 
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there exist many types of importin α and β that are available to bind to a single NLS.  Six 
importin α species have been characterized in higher eukaryotes (Goldfarb et al., 2004) 
and at least 21 members comprise the importin β family in humans (Görlich and Kotay, 
1999).  Nuclear-targeting sequences are able to functionally interact with multiple import 
factors.  For instance, the highly basic ribosomal protein L23a NLS is bound by at least 
four different importin β receptors (Jäkel and Görlich , 1998).  In addition, the import 
receptors that bind the NL1 sequence of GR, mentioned previously, have been studied 
(Freedman and Yamamoto, 2004).  NL1 was recognized by importin α, importin 7, and 
importin 8, with importins 7 and 8 being members of the importin β family.  A GR mutant 
containing only NL1 was imported in the presence of importin α/β or importin 7, but not 
in the presence of importin 8 (Freedman and Yamamoto, 2004).  Therefore, a single 
signal may be recognized by numerous import receptors, leading to multiple pathways 
into the nucleus. 
Secondly, a single import receptor is capable of recognizing a diverse set of 
biochemically distinct import sequences.  With GR, importins 7 and 8 were able to bind 
both NLS in GR, NL1 and NL2 (Freedman and Yamamoto, 2004).  In addition, a member 
of the importin β family known as transportin recognizes the NLS of the hnRNP protein 
A1 which has only one essential basic amino acid (Gorlich and Kotay, 1999).  
Transportin also interacts with the NLS of the ribosomal protein L23a in the BIB domain, 
which is highly basic (Görlich and Kotay, 1999).  Therefore, members of the importin β 
family bind to different NLS.  This capability also exists with importin α proteins.  It has 
long been known that importin α binds at least two classes of NLS, monopartite and 
bipartite.  Recently, three novel NLS classes have been added to the known types of 
“classical” NLS recognized by importin α (Kosugi et al., 2009).  Through multiple levels 
of interaction with import receptors, NLS-bearing proteins have access to a diverse set 
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of pathways into the nucleus.  
 The presence of two import signals suggests that TRα utilizes multiple pathways 
into the nucleus.  A closer analysis of the A/B and hinge import sequences of TRα shows 
them to be a monopartite (M.S. Mavinakere and L.A. Allison, unpublished results) and 
bipartite classical NLS, respectively.  As mentioned, importin α’s are understood to be 
the primary binding partners of classical NLS.  Assuming that TRα utilizes the classical 
transport model, the importin α/cargo complex would have to converge on a final 
common pathway, importin β, to achieve import.  However, preliminary data from an 
ongoing siRNA knockdown study in our lab suggest that knockdown of importin β alone 
does not significantly decrease the nuclear population of TRα (V.R. Roggero and L.A. 
Allison, unpublished results).  Likewise, NL1 in the hinge region of GR is a classical 
monopartite NLS, yet it was found to be bound and imported by importin 7, in addition to 
importin α/β (Freedman and Yamamoto, 2004).  Consequently, despite the presence of 
classical NLS, TRα may be primarily bound by importin β family members, and not 
significantly by an importin α/importin β complex.  In future research it will be useful to 
use yeast two hybrid screens and GST-pull down assays in order to define specific 
importin binding partners of TRα.  Furthermore, it will be necessary to show that 
knockdown of these importins significantly decreases the presence of TRα in the 
nucleus.  In this way, multiple pathways for the import of TRα can be characterized.   
Multiple NLS and Import Efficiency 
The observation that the hinge domain exhibited a nuclear population in a greater 
number of cells compared to the A/B domain may indicate that the hinge domain NLS 
accesses a pathway with a greater efficiency of import.  The relationship between NLS-
to-importin binding affinity and the efficiency of import was studied in Saccharomyces 
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cerevisiae, a yeast model system for nuclear import.   The researchers found that there 
was a positive correlation between the level of affinity of various NLSs for importin α and 
the extent of nuclear localization (Hodel et al., 2006).  In general, bipartite NLS have a 
greater affinity for importin α than do monopartite NLS (Hodel et al., 2006).  Accordingly, 
the researchers found that a bipartite variant of the SV40 NLS was found only in the 
nucleus whereas the original monopartite SV40 NLS was found in both the nucleus and 
the cytoplasm (Hodel et al., 2006).  In this light, it is not surprising that the hinge domain 
of TRα, which contains a bipartite NLS, possessed a greater nuclear localization than 
the A/B domain, which contains a monopartite NLS.   
After elucidating the specific importins interacting with TRα, it would be useful to 
“dissect” the NLS sequences in the A/B and hinge domains of TRα and to determine the 
relative importance of each residue for interaction with transport receptors and overall 
localization (Hodel et al., 2001).  Ongoing work in the Allison lab has made progress on 
these objectives.  Given TRα's possession of two NLSs, it provides an ideal model 
system for understanding the dynamics of monopartite and bipartite NLS/importin 
interactions and nuclear import.  A greater understanding of TRα NLS binding affinity 
and import efficiency will greatly contribute to achieving the goal of a “comprehensive 
quantitative model for nuclear transport” (Hodel et al., 2001).  
The Nuclear Export of TRα is Primarily Mediated by the Ligand-Binding Domain 
 The A/B and hinge domains displayed NLS activity; thus, the DNA-binding 
domain (DBD) and/or the ligand-binding domain (LBD) must contain the sequences 
involved in mediating export.  Individually, the DBD and LBD fusion proteins showed a 
predominantly cytoplasmic distribution in the majority of cells, but this is not enough 
evidence to conclude that these domains possess export activity.  To study this further, 
the DBD and LBD were analyzed in combination with the NLS-containing domains.  In 
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contrast to the slight effect on localization seen with the DBD-containing combination 
domains, the LBD-containing combination constructs localized exclusively to the 
cytoplasm in all cell lines, in what appeared to be a complete reversal of the NLS-activity 
of the hinge domain.  Therefore, these observations suggest that the LBD is the primary 
mediator of nuclear export in TRα.   
 Previous studies have investigated the nuclear export activity of TRα.  One report 
from our lab observed that the localization of TRα was not affected by LMB, a potent 
inhibitor of CRM-1 dependent export, in heterokaryon assays (Bunn et al., 2001).  
However, this assay involves PEG-induced fusion of cytosols which was observed to 
lead to substantial changes in the cellular environment, including an increase in the level 
of calreticulin (CRT), an export factor for some nuclear receptors (Walther et al., 2003).  
If CRT was involved in the export of TRα, then the increase in CRT would have mitigated 
the effects of LMB-induced reduction of CRM-1 export.  Using monokaryon assays and 
fluorescence recovery after photobleaching (FRAP) to better emulate physiological 
conditions, a later study from our lab found that the export of TRα does at least in part 
depend on CRM1 (Grespin et al., 2008).  This study determined that TRα exits the 
nucleus via a cooperative export pathway involving CRM-1 and CRT (Grespin et al., 
2008). In separate reports, GR has also been shown to be reliant on CRM-1 and CRT for 
export (Savory et al., 1999; Holsaka et al., 2001).  With GR, a 15 amino acid sequence 
between the zinc fingers of the DBD was shown to interact with CRT and be exported 
from the nucleus (Black et al., 2001).  However, it is not entirely clear to what sequences 
in TRα CRT would bind to mediate such export.  Given that the DBD of TRβ was 
observed to possess export activity when fused to a GFP reporter (Black et al., 2001), it 
is possible that the DBD of TRα may contain a CRT-interacting NES as well.  This may 
partially explain the reduction in nuclear localization of the HD, when attached to the 
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DBD (discussed below).   
 Concerning CRM-1 interacting NES, it appears that nuclear receptors including 
TRα lack the typical CRM-1 interacting leucine-rich NES (Grespin et al., 2008).  
However, CRM-1 NES typically bind CRM-1 with low affinity and employ adaptor 
proteins to strengthen the interaction (Grespin et al., 2008).  The NetNES 1.1 prediction 
server (http://www.cbs.dtu.dk/services/NetNES/, la Cour et al., 2004) predicts at least 
one CRM-1 dependent NES in the LBD of TRα (Appendix II); however, the exact 
sequence for this NES is not known, as of now.  In future research, it will be useful to 
isolate the putative NESs in the DBD and LBD of TRα in order to determine their specific 
role in the cooperative CRT/CRM-1 pathway for the export of TRα.   
The Ligand-Binding Domain and Hormone-Induced Nuclear Accumulation of TR 
Isoforms 
The existence of a hormone-induced increase in nuclear localization of TRα in 
mammalian cells has been a subject of debate.  Using immunocytochemistry in fixed 
monkey kidney cells, one group observed that the presence of the TH ligand did not 
have a significant effect on the intracellular localization of rat TRα1 (Lee and Mahdavi, 
1993).  However, later literature suggested that these results should be confirmed using 
kinetic studies in living cells, given that TRβ1 was observed to significantly increase in 
the nucleus in the presence of TH using live cell imaging of monkey kidney cells (Zhu et 
al., 1998).  It is generally understood that TRβ has a greater cytoplasmic population than 
TRα at steady-state, so it may be the case that a greater shift in distribution is seen with 
this isoform upon TH administration.  Another study showed that there was no difference 
in the nuclear population of TRα in the presence and absence of TH in mammalian cell 
heterokaryons (Bunn et al., 2001).  However, increased nuclear retention of TRα was 
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seen in nuclear extracts from Xenopus oocytes in the presence of TH (Bunn et al., 
2001), demonstrating an inter-species difference in the effect of TH on TRα shuttling.  
Notably, in mammalian systems, the effects of TH on TRα shuttling have only been 
studied in HeLa and NIH/3T3 (mouse fibroblast) cells.  Although it was not statistically 
significant, in this study there was a slight decrease in the number of cells with a nuclear 
localization of full-length GFP-TRα in neuronal compared to non-neuronal cell lines.  
Since the serum included in cell culture medium contains undefined amounts of TH, this 
was in the presence of TH.  It would be interesting to determine whether this decrease is 
pronounced with cells grown in TH-depleted conditions.  It is possible that TRα may 
undergo more distinct TH-dependent effects in different cell types, therefore it is of 
interest to study the effects of hormone binding on TRα localization in additional 
mammalian systems, including neuronal cells. 
Given the dominant role of the LBD in the export of TRα, NES-masking may 
partly explain the TH-induced increase in the nuclear population of TRα in Xenopus 
oocytes and of TRβ1 in monkey kidney cells.  In the absence of the A/B domain NLS, the 
LBD-containing combination domain constructs localized completely to the cytoplasm in 
all cell lines.  As previously mentioned, a TRα mutant lacking the hinge domain also 
localized exclusively to the cytoplasm (Lee and Mahdavi, 1993).  In contrast, full-length 
GFP-TRα, containing the A/B and hinge NLS, localized completely to the nucleus.  This 
suggests that the export signals of the LBD would dominate over the signals for import if 
the NLS of either the A/B or hinge domain were in some way masked.  Alternatively, the 
signals for import may override the signals for export if the NES of the LBD were in some 
way masked.  To account for the increase of TRβ1 in the nucleus in the presence of TH, 
Zhu et al. proposed that TH binding induced a conformational change in the protein that 
unmasked the TRβ1 hinge domain NLS and thereby induced entry into the nucleus.  
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However, this model only accounts for the effects that hormone binding may have on 
import.  Bunn et al. suggested that ligand binding induced reorganizations in the 3-D 
structure of TRα which led to increased affinity for intranuclear binding sites; thereby 
increasing the nuclear retention of the receptor in Xenopus oocytes.  In addition to these 
two mechanisms, a third may conceivably be in effect, i.e. NES-masking.  TH binding 
could induce structural reorganizations that preclude the NESs in the LBD from binding 
exportins, thereby decreasing export and increasing the steady-state nuclear 
accumulation of TRα.  Many examples of NES regulation via masking exist in the 
literature; conformational rearrangements can expose an NES, or alternatively, 
interactions with other molecules can hide the NES (Stommel et al., 1999; Seimiya et al., 
2000; Craig et al., 2002).  Of note, given that the LBD is also involved in dimerization, an 
NES-masking model may also help explain increases in nuclear accumulation of TRα 
and β upon heterodimerization with RXR.  An NES was identified in the LBD of the 
vitamin-D receptor; the receptor was observed to accumulate to a greater extent in the 
nucleus when associated with RXR (Prüfer and Barsony, 2002).   
As previously mentioned, research in our lab predicts more than one NES in the 
LBD of TRα (M.S. Mavinakere and L.A. Allison, unpublished results).  Given that the 
LBD of TRβ1 shares 82% sequence homology with the LBD of TRα1 (used in this study) 
(Cheng, 2000), it would be interesting to determine whether there are NES present in the 
LBD of TRβ1 whose masking may play a role in hormone-dependent nuclear 
accumulation.  The NetNES 1.1 NES prediction server 
(http://www.cbs.dtu.dk/services/NetNES/, la Cour et al., 2004) was used to search for a 
CRM-1 interacting NES in human TRβ1 (Appendix II).  The server predicted an NES in 
the LBD of TRβ1, which provides preliminary evidence that ligand binding may mask an 
NES in this region.  Additional sequence analyses are merited.   
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Further efforts to better characterize the hormone-independent and dependent 
translocation properties of TRα must include live cell imaging of the receptor in neuronal 
cells before and after hormone treatment.   Specific studies should also be done to 
assess the level of interaction with export factors in the presence and absence of 
hormone in TRα and TRβ systems.  These routes of experimentation may reveal a new 
model of TH-dependent transport that includes a role for NES-masking.    
Effect of the DNA-Binding Domain on the Nucleocytoplasmic Shuttling of TRα 
 The data from the combination domain constructs showed that the presence of 
the DNA-binding domain had opposing effects on the nuclear localization of the A/B and 
hinge domains.  The addition of the DBD to the A/B domain led to an increase in the 
number of cells displaying a nuclear localization of the fusion protein, whereas the 
addition of the DBD to the hinge domain led to a decrease in the number of cells with a 
nuclear localization.  A similar pattern was seen in all cell lines tested, suggesting that 
the effects of the DBD are not due to chance.  However, more experiments will be 
necessary to determine whether the results are statistically significant.   
 The DBD of TRα, as mentioned previously, is the site of a potential CRT-
interacting sequence, which would mean that this domain participates in nuclear export.  
This would explain the decrease in the number of cells with a nuclear localization and 
the shift to the cytoplasm seen with the DBD-HD combination construct.  However, 
assuming that the DBD does contain a sequence involved in export, it is not clear how 
the A/B-DBD combination construct was seen to increase in the number of cells 
possessing a nuclear localization, compared to the A/B domain alone.  This apparent 
contradiction could be explained by the effect of co-regulatory protein interactions on the 
dynamics of receptor-DNA interaction.  Whereas nuclear receptors were previously 
thought to reside in the nucleus bound tightly to chromatin in the presence of ligand, it is 
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now understood that receptors undergo rapid exchange between a DNA-bound and 
unbound state (McNally et al., 2001).  It is possible that the interaction with co-regulating 
proteins, mediated by the transactivation function of the A/B domain, actually increased 
the strength of binding between the A/B-DBD fusion protein and DNA in the nucleus.  
This would serve to increase the transient time that the fusion protein was bound to DNA 
and decrease the overall time that the DBD was available for binding to CRT, thereby 
inhibiting export and increasing retention in the nucleus.  Although the hinge domain has 
been reported to interact with the corepressor, NCoR (Horlein et al., 1995), it is 
presumably not as active as the A/B domain.  Therefore, the lesser amount of time that 
the DBD-HD fusion protein is bound to DNA would lead to greater accessibility of the 
CRT binding site in the DBD and an increase in export activity.  Alternatively, the hinge 
NLS in the DBD-HD construct could be partially masked, which would also lead to the 
decrease in nuclear localization that was observed.   
The hypotheses about the effect of the DBD on the NLS activity of the A/B and 
hinge domains need to be confirmed with additional experiments.  One would expect a 
decrease in nuclear localization of the A/B-DBD combination construct if specific 
coregulator interacting regions in the A/B domain were mutated.  Conversely, if the 
decrease in nuclear localization seen with the DBD-HD construct is due to CRT activity, 
mutations in the putative CRT NES of the DBD would be expected to prevent this effect.  
These studies should be done to confirm these interesting results. 
Cell-Type Specific Regulation of the Shuttling of TRα  
 A unique aspect of this thesis was the use of neuronal and non-neuronal cell 
lines in the study of the nucleocytoplasmic shuttling dynamics of TRα.  This feature 
added depth to the work, because the control of nuclear transport may be a means of 
regulating cell-type specific differences in function.  The study of TRα in neuronal cells is 
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particularly important because TRα is critical to the correct growth, development and 
function of the nervous system as a whole.  The differences seen in the localization 
patterns of the individual and combination domain constructs in this study may underlie 
fundamental variations in the regulation of nuclear transport between cell lines and begin 
to reveal the complexity of the regulatory interactions that control cellular function.   
The localization patterns of the individual and combination domain constructs 
differed between non-neuronal and neuronal cell lines.  In short, the A/B and hinge 
domain appeared to have a nuclear population in a greater percentage of AML-12 cells 
compared to the other cell lines.  This could indicate that there is greater nuclear 
retention in AML-12 cells or that these cells express higher levels of more efficient TRα-
interacting import receptors.  Alternatively, these differences may not be significant at all, 
because only one replicate of the transfection of the individual domains in AML-12 cells 
was performed due to time constraints.   
Next, an overall shift to the cytoplasm occurred with the A/B domain in PC-12 
and SH-SY5Y cells, compared to the non-neuronal cell lines.  This manifested in a 
decreased nuclear localization and an increased cytoplasmic distribution and to a 
greater extent, an increased whole cell distribution of the fusion protein.  Possible 
explanations include cell-type specific differences in post-translational modifications, 
protein-protein interactions, and expression of importins.  Phosphorylation of the A/B 
domain is a potential target of post-translational modification, as there are seven serines 
present in this region.  Phosphorylation of the DNA-binding domain of a number of 
nuclear receptors shifted their localization to the cytoplasm (Sun et al., 2007).  It is 
conceivable to hypothesize that phosphorylation of the A/B domain causes it to increase 
in the cytoplasm and that this process may be more active in neuronal cells.  Protein 
kinase and phosphatase inhibitors should be used to study the effect of phosphorylation 
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on the localization of the A/B domain in neuronal and non-neuronal cell lines.   
It also may be likely that the A/B domain NLS accesses a less efficient import 
pathway in neuronal cell lines.  Many reports have shown that import receptors are 
differentially expressed in a wide variety of human tissues (Köhler et al., 1997; Nadler et 
al., 1997; Hosokawa et al., 2008).  One study determined the specific distribution of the 
importin α family members and importin β in the mouse central nervous system by in situ 
hybridization (Hosokawa et al., 2008).  Importin α1 and α4 were more restricted in their 
expression compared to importin α5, α7, α3 and β1, which were ubiquitously expressed 
at moderate to high levels throughout the brain and spinal cord (Hosokawa et al., 2008).  
Another study characterized differences in importin α expression between 11 human and 
3 mammalian cell lines (Kohler et al., 1997).  These results indicate that there may also 
be differences in import factor expression between HeLa, AML-12, PC-12 and SH-SY5Y 
cells.  The different import factors in the different cell lines could be mediating the cell-
type specific variation in TRα domain localization.   
An additional difference between neuronal and non-neuronal cell lines was the 
shift to the cytoplasm seen with DBD-containing combination domain constructs in 
neuronal cells.  While this shift could also be due to the differences in import factor 
expression between cell lines or to interference with the NLS through improper folding of 
the artificial construct, the involvement of the DBD may also implicate an increase in 
CRT-mediated export in neuronal cells.  Specifically, an increase in CRT expression in 
neuronal cells could account for the increase in cytoplasmic localization.  One report 
found developmental stage specific differences in the expression of CRT in regions of 
the monkey brain, heart, lung, liver, stomach, spleen and kidney (Higashino and 
Kageyama, 2008).  A cursory observation of these data reveals that the levels of CRT in 
the neuronal tissues were higher than non-neuronal tissues in 6-year old adult monkeys.  
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However, the study was designed to quantify developmental-stage specific differences in 
the expression of CRT in various tissues, and not individual tissue-specific differences, 
necessarily.  Nevertheless, this report provides preliminary evidence that there may be 
differences in CRT expression in neuronal cells.  These differences may play a role in 
the slight shift of TRα combination domains to the cytoplasm that was observed in the 
neuronal cell lines in this study.   
Differences in nuclear localization of nuclear receptors between cell types may 
serve as a method of regulating the specific function of the nuclear receptor in the tissue.  
TRα plays a role in the differentiation of many neuronal cells, including neural stem cells 
(Lemkine et al., 2005), oligodendrocytes (Billon et al., 2002), cerebellar GABAergic 
interneurons (Manzano et al., 2007) and the PC-12 cell line (Munoz et al., 1993).  While 
tissue-specific and developmental-stage specific expression of TRα (Bradley et al., 
1992) and release of TH (Williams, 2008) certainly regulate much of these processes, 
events at the cellular level must be in play as well.  In particular, the shift of TRα from 
one compartment to another during differentiation could be one way that a cell’s nuclear 
transport machinery regulates major phenotypic changes.  For example, a recent report 
has shown that a switch in the expression of an importin α subtype directly mediates 
neural differentiation in mice (Yasuhara et al., 2007).  A complete change in import factor 
expression would have broad effects on the shuttling dynamics of a host of proteins, 
including TRα, if the specific import factors interacted with the receptor.  An example of 
this may be found in PC-12 cells.  It has been shown that TRα represses SNAP-25 in 
the presence of TH, a protein required for neuritic outgrowth and synaptogenesis after 
differentiation, in PC-12 cells (Langley et al., 2002).  Therefore, it is conceivable that a 
sequestration of TRα to the cytoplasm during PC-12 differentiation could increase 
SNAP-25 expression and lead to enhanced extension of neural processes.  A change in 
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import factor expression could decrease TRα import and lead to the accumulation of 
TRα in the cytoplasm.  Since TRα is involved in the regulation of many other genes 
involved in neural development, it is of interest whether global adjustments in nuclear 
localization during differentiation shift TRα to the nucleus or the cytoplasm, thus leading 
to coordinated changes in the regulation of specific factors and committing an 
undifferentiated cell to a particular fate.   
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Conclusions and Future Direction 
 Through the study of individual and combination domain constructs of TRα in 
neuronal and non-neuronal cell lines, we have a much clearer understanding of the 
nucleocytoplasmic shuttling of TRα as well as many avenues to pursue in future 
research.  We now have strong evidence to believe that full import of TRα is achieved 
through the cooperative activity of the A/B and hinge domain nuclear localization 
sequences.  To verify this hypothesis, it is imperative to study the effect of mutations in 
the NLSs of the A/B and hinge domain on the overall localization of the receptor.  Since 
TRα contains two import signals, it is likely that it obtains entry to the nucleus through 
multiple import pathways; however, the specific import factors that bind to TRα have yet 
to be determined.  Binding assays and import factor knockdown studies must be done to 
show that suspected factors actually mediate transport.  Ongoing work in the Allison lab 
is pursuing these objectives. 
Our data show that the export of TRα is primarily mediated by the ligand-binding 
domain in all cell lines studied, indicating a common feature shared by the neuronal and 
non-neuronal cell lines tested.  While it is known that TRα has more than one NES, the 
exact type of these NESs has not been elucidated, nor is it known whether they are 
novel sequences.  Mutational analysis of the suspected NESs in TRα is necessary to 
determine the specific properties of the NESs in TRα.   
Finally, the A/B and hinge domains displayed cell-type specific localization 
patterns between neuronal and non-neuronal cell lines.   A number of factors could 
account for this difference, including post-translational modifications, protein-protein 
interactions and differential expression of importins.  Studies that employ protein kinase 
and phosphotase inhibitors in neuronal and non-neuronal cell lines will help to better 
understand phosphorylation and nuclear transport.  Next, to test whether the differential 
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expression of importins accounts for the observations, constructs that contain only the 
NLSs should be tested in these cell lines.  If differences are confirmed in this context, 
other strategies can be pursued to address this issue, such as quantifying the 
expression of TRα-interacting import factors in HeLa, AML-12, PC-12 and SH-SY5Y cell 
lines.   
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Appendix I – Complete Cell Count Data from Non-Neuronal and Neuronal Cell Lines 
 
Complete Cell Counts and Averages of HeLa Cells: 
 
Individual 
Domains 10/1/08 (w/ *) 04/01/09 
Scoring Category Nuclear 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
A/B 73 0 48 121 61 0 73 134 
DBD 0 107 3 110 0 91 31 122 
Hinge 104 0 9 113 99 0 33 132 
LBD 0 108 1 109 0 113 3 116 
GFP-TRα 110 0 2 112 122 0 2 124 
GFP-GST-GFP 0 109 5 114 0 91 46 137 
 
 
Individual Domains Nuclear Cytoplasmic Whole Cell 
(in percentages) 1 2 Avg StDev 1 2 Avg StDev 1 2 Avg StDev 
A/B 60  46  53  10 0  0  0  0 40  54  47  10 
DBD 0  0  0  0 97  75  86  16 3  25  14  16 
Hinge 92  75  84  12 0  0  0  0 8  25  16  12 
LBD 0  0  0  0 99  97  98  1 1  3  2  1 
GFP-TRα 98  98  98  0 0  0  0  0 2  2  2  0 
GFP-GST-GFP 0  0  0  0 96  66  81  21 4  34  19  21 
 
 
Combinations 09/10/08 09/03/08 
Scoring 
Category 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
A/B-DBD 101 0 8 109 75 0 44 119 
DBD-HD 94 0 16 110 42 0 72 114 
DBD-HD-LBD 0 106 9 115 0 107 11 118 
HD-LBD 0 110 6 116 0 110 11 121 
GFP-TRα 108 0 5 113 120 0 3 123 
GFP-GST-GFP 0 104 3 107 0 100 22 122 
 
 
Combinations Nuclear Cytoplasmic Whole Cell 
(in percentages) 1 2 Avg StDev 1 2 Avg StDev 1 2 Avg StDev 
A/B-DBD 93  63  78 21 0  0  0 0 7  37  22 21 
DBD-HD 85  37  61 34 0  0  0 0 15  63  39 34 
DBD-HD-LBD 0  0  0 0 92  91  91 1 8  9  9 1 
HD-LBD 0  0  0 0 95  91  93 3 5  9  7 3 
GFP-TRα 96  98  97 1 0  0  0 0 4  2  3 1 
GFP-GST-GFP 0  0  0 0 97  82  90 11 3  18  10 11 
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Complete Cell Counts and Averages of AML-12 Cells: 
 
Individual Domains 11/12/2008 
Scoring Category Nuclear Cytoplasmic Whole cell Total 
A/B 129 3 13 145 
DBD 0 132 2 134 
HD 139 0 2 141 
LBD 0 137 0 137 
GFP-TRα 133 0 1 134 
GFP-GST-GFP 0 116 14 130 
 
Individual Domains 
(percentages from  
the single count) 
Nuclear Cytoplasmic Whole Cell 
A/B 89 2 9 
DBD 0 99 1 
Hinge 99 0 1 
LBD 0 100 0 
GFP-TRα 99 0 1 
GFP-GST-GFP 0 89 11 
 
 
Combinations 2/4/2009 1/28/2009 
Scoring 
Category 
Nuclea
r 
Cytoplasmi
c 
Whole 
cell 
Tota
l 
Nuclea
r 
Cytoplasmi
c 
Whole 
cell 
Tota
l 
A/B-DBD 122 0 13 135 121 0 11 132 
DBD-HD 104 2 25 131 112 0 13 125 
DBD-HD-LBD 1 119 7 127 0 104 34 138 
HD-LBD 0 113 10 123 0 144 7 151 
GFP-TR 124 0 6 130 121 0 3 124 
GFP-GST-GFP 0 115 18 133 0 103 24 127 
 
 
Combination Domains Nuclear Cytoplasmic Whole Cell 
(in percentages) 1 2 Avg StDev 1 2 Avg StDev 1 2 Avg StDev 
A/B-DBD 90  92  91 1 0  0  0 0 10  8  9 1 
DBD-HD 79  90  84 7 2  0  1 1 19  10  15 6 
DBD-HD-LBD 1  0  0 1 94  75  85 13 6  25  15 14 
HD-LBD 0  0  0 0 92  95  94 2 8  5  6 2 
GFP-TRα 95  98  96 2 0  0  0 0 5  2  4 2 
GFP-GST-GFP 0  0  0 0 86  81  84 4 14  19  16 4 
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Complete Cell Counts and Averages of PC-12 Cells: 
 
Individual 
Domains 11/05/08 2/9/09 - 01 
Scoring Category Nuclear 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
A/B 32 5 65 102 15 11 101 127 
DBD 0 105 14 119 0 109 15 124 
Hinge 88 5 9 102 98 2 31 131 
LBD 0 104 1 105 0 129 0 129 
GFP-TRα 86 0 18 104 132 0 4 136 
GFP-GST-GFP 0 93 15 108 0 108 15 123 
 
Individual Domains 2/9/09 - 02 
 Nuclear Cytoplasmic Whole Cell Total 
A/B 14 5 93 112 
DBD 0 106 13 119 
Hinge 97 6 32 135 
LBD 0 123 1 124 
GFP-TRα 109 0 15 124 
GFP-GST-GFP 0 106 9 115 
 
Individ
ual 
Domai
ns 
Nuclear Cytoplasmic Whole Cell 
(in 
percen
tages) 
1 2 3 Avg 
StD
ev 1 2 3 
Av
g 
StD
ev 1 2 3 
Av
g 
StD
ev 
A/B 31 12 13 19 11 5 9 4 6 2 64 80 83 75 10 
DBD 0 0 0 0 0 88 88 89 88 1 12 12 11 12 1 
Hinge 86 75 72 78 8 5 2 4 4 2 9 24 24 19 9 
LBD 0 0 0 0 0 99 100 99 99 1 1 0 1 1 1 
GFP-
TRα 83 97 88 89 7 0 0 0 0 0 17 3 12 11 7 
GFP-
GST-
GFP 
0 0 0 0 0 86 88 92 89 3 14 12 8 11 3 
 
Combinations 2-4-09-01 2-4-09-02 
Scoring 
Category 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
A/B-DBD 31 9 76 116 72 20 56 148 
DBD-HD 25 34 72 131 39 20 68 127 
DBD-HD-LBD 0 129 2 131 0 127 2 129 
HD-LBD 0 124 1 125 0 125 0 125 
GFP-TRα 129 0 8 137 109 0 16 125 
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GFP-GST-GFP 0 129 2 131 0 122 9 131 
 
Combin
ation 
Domains 
Nuclear Cytoplasmic Whole Cell 
(in 
percenta
ges) 
1 2 Avg StDev 1 2 Avg 
StDe
v 1 2 Avg 
StDe
v 
A/B-
DBD 27  49  38 16 8  14  11 4 66  38  52 20 
DBD-HD 19  31  25 8 26  16  21 7 55  54  54 1 
DBD-
HD-LBD 0  0  0 0 98  98  98 0 2  2  2 0 
HD-LBD 0  0  0 0 99  100  100 1 1  0  0 1 
GFP-
TRα 94  87  91 5 0  0  0 0 6  13  9 5 
GFP-
GST-
GFP 
0  0  0 0 98  93  96 4 2  7  4 4 
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Complete Cell Counts and Averages of SH-SY5Y Cells: 
 
Individual 
Domains 10/01/08 04/01/09 
Scoring Category Nuclear 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
A/B 31 17 60 108 19 16 74 109 
DBD 0 100 2 102 0 87 13 100 
Hinge 87 2 10 99 35 3 24 62 
LBD 0 101 0 101 0 91 3 94 
GFP-TRα 106 2 7 115 92 0 9 101 
GFP-GST-GFP 0 105 6 111 0 61 14 75 
 
Individual Domains Nuclear Cytoplasmic Whole Cell 
(in percentages) 1 2 Avg StDev 1 2 Avg StDev 1 2 Avg StDev 
A/B 29  17  23 8 16  15  15 1 56  68  62 9 
DBD 0  0  0 0 98  87  93 8 2  13  7 8 
Hinge 88  56  72 22 2  5  3 2 10  39  24 20 
LBD 0  0  0 0 100  97  98 2 0  3  2 2 
GFP-TRα 92  91  92 1 2  0  1 1 6  9  7 2 
GFP-GST-GFP 0  0  0 0 95  81  88 9 5  19  12 9 
 
 
Combinations 2-11-09-01 2-11-09-02 
Scoring 
Category: 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
Nuclea
r 
Cytoplasmi
c 
Whole 
Cell 
Tota
l 
A/B-DBD 38 14 60 112 67 10 42 119 
DBD-HD 16 18 148 182 51 18 39 108 
DBD-HD-LBD 0 103 6 109 0 100 9 109 
HD-LBD 0 117 2 119 0 103 6 109 
GFP-TRα 119 2 5 126 108 0 7 115 
GFP-GST-GFP 0 112 5 117 0 109 0 109 
 
Combination 
Domains Nuclear Cytoplasmic Whole Cell 
(in percentages) 1 2 Avg StDev 1 2 Avg StDev 1 2 Avg StDev 
A/B-DBD 34 56 45 16 13 8 10 3 54 35 44 13 
DBD-HD 9 47 28 27 10 17 13 5 81 36 59 32 
DBD-HD-LBD 0 0 0 0 94 92 93 2 6 8 7 2 
HD-LBD 0 0 0 0 98 94 96 3 2 6 4 3 
GFP-TRα 94 94 94 0 2 0 1 1 4 6 5 1 
GFP-GST-GFP 0 0 0 0 96 100 98 3 4 0 2 3 
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Appendix II – NetNES Prediction of NES in TRα1 and TRβ1 
TRα1: 
 
#Seq-Pos-Residue           ANN     HMM     NES   Predicted 
#--------------------------------------------------------- 
// 
Sequence-240-S            0.074   0.024   0.000      - 
Sequence-241-E            0.100   0.024   0.000      - 
Sequence-242-L            0.121   0.132   0.000      - 
Sequence-243-P            0.078   0.130   0.000      - 
Sequence-244-C            0.144   0.130   0.000      - 
Sequence-245-E            0.079   0.130   0.000      - 
Sequence-246-D            0.106   0.130   0.000      - 
Sequence-247-Q            0.109   0.130   0.000      - 
Sequence-248-I            0.093   0.309   0.030      - 
Sequence-249-I            0.110   0.558   0.287      - 
Sequence-250-L            0.102   0.586   0.305      - 
Sequence-251-L            0.546   0.594   0.818      Yes 
Sequence-252-K            0.366   0.588   0.464      - 
Sequence-253-G            0.099   0.588   0.462      - 
Sequence-254-C            0.100   0.588   0.464      - 
Sequence-255-C            0.120   0.588   0.466      - 
Sequence-256-M            0.126   0.589   0.471      - 
Sequence-257-E            0.116   0.588   0.374      - 
Sequence-258-I            0.798   0.590   0.878      Yes 
Sequence-259-M            0.135   0.096   0.000      - 
Sequence-260-S            0.088   0.085   0.000      - 
Sequence-261-L            0.227   0.092   0.006      - 
Sequence-262-R            0.066   0.014   0.000      - 
Sequence-263-A            0.099   0.014   0.000      - 
Sequence-264-A            0.076   0.014   0.000      - 
Sequence-265-V            0.084   0.016   0.000      - 
Sequence-266-R            0.078   0.016   0.000      - 
Sequence-267-Y            0.109   0.016   0.000      - 
Sequence-268-D            0.085   0.016   0.000      - 
// 
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TRβ1: 
 
 
#Seq-Pos-Residue           ANN     HMM     NES   Predicted 
#--------------------------------------------------------- 
// 
Sequence-300-D            0.112   0.113   0.000      - 
Sequence-301-Q            0.102   0.113   0.000      - 
Sequence-302-I            0.102   0.244   0.000      - 
Sequence-303-I            0.104   0.417   0.151      - 
Sequence-304-L            0.097   0.434   0.154      - 
Sequence-305-L            0.513   0.438   0.654      Yes 
Sequence-306-K            0.321   0.433   0.291      - 
Sequence-307-G            0.099   0.433   0.291      - 
Sequence-308-C            0.100   0.433   0.290      - 
Sequence-309-C            0.120   0.433   0.294      - 
Sequence-310-M            0.126   0.434   0.300      - 
Sequence-311-E            0.116   0.434   0.210      - 
Sequence-312-I            0.769   0.435   0.716      Yes 
Sequence-313-M            0.132   0.064   0.000      - 
Sequence-314-S            0.084   0.057   0.000      - 
Sequence-315-L            0.218   0.063   0.000      - 
Sequence-316-R            0.066   0.013   0.000      - 
Sequence-317-A            0.094   0.013   0.000      - 
Sequence-318-A            0.074   0.013   0.000      - 
Sequence-319-V            0.092   0.014   0.000      - 
Sequence-320-R            0.075   0.014   0.000      - 
Sequence-321-Y            0.118   0.014   0.000      - 
Sequence-322-D            0.084   0.014   0.000      - 
Sequence-323-P            0.092   0.014   0.000      - 
Sequence-324-E            0.081   0.014   0.000      - 
Sequence-325-S            0.080   0.014   0.000      - 
Sequence-326-E            0.071   0.014   0.000      - 
Sequence-327-T            0.072   0.015   0.000      - 
Sequence-328-L            0.103   0.068   0.000      - 
Sequence-329-T            0.069   0.066   0.000      - 
// 
